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DNA methylation is an indispensable process during development and maintaining the DNA 
methylation pattern after DNA replication is crucial for proper cellular function in mammals. 
Misregulation of this process is involved in cancer formation. The key protein is the maintenance DNA 
methyltransferase 1 (Dnmt1), an essential epigenetic factor that reestablishes methylation of 
hemimethylated CpG sites generated during DNA replication in S phase. Two domains of Dnmt1, the 
proliferating cell nuclear antigen (PCNA) binding domain (PBD) and the targeting sequence (TS) 
domain are responsible for targeting the enzyme to replication sites and to constitutive 
heterochromatin. However, their cell cycle-dependent coordinated action and regulation are still 
unclear. In order to understand the regulation of Dnmt1 as well as other nuclear factors, they have to 
be studied not only in vitro, but also under dynamic in vivo conditions. Advanced fluorescence 
microscopy offers a variety of methods, to gain insights into epigenetic regulation in vivo. 
Therefore, we set out to dissect the cell cycle-dependent dynamics of Dnmt1. In our approach, we 
combined fluorescence recovery after photobleaching (FRAP) with kinetic modeling, complemented 
by 3D-structured illumination microscopy, which allowed us to obtain detailed information about the 
spatio-temporal dynamics of Dnmt1 and its regulation. By analyzing GFP-Dnmt1 mutants, we showed 
that both the PBD- and the TS domain-mediated interactions are necessary and sufficient for the 
localization and the dynamics of Dnmt1 in S phase. Based on our customized kinetic model, we 
estimated an average target binding time for the PBD to PCNA and the TS domain to constitutive 
heterochromatin of about 10 s and 22 s, respectively.  Altogether, we propose a two-loading-platform 
model, in which PCNA and heterochromatin function as relatively immobile platforms during S phase. 
In early S phase, binding of the PBD to PCNA predominates. In late S phase, the heterochromatic 
marks, the TS domain binds to, are in close proximity to replication sites, leading to a strong TS 
domain-mediated interaction that dominates the Dnmt1 dynamics in late S phase. 
Furthermore, fluorescent microscopy and biochemical methods enabled us to further investigate the 
proteins Uhrf (ubiquitin-like, containing PHD and RING finger domains) 1, an essential factor for 
maintenance methylation in vivo, its homologue Uhrf2 and the histone variant H2A.Z, exemplifying 
another level of epigenetic regulation. We demonstrated, for example, that an alternative splice 
variant of H2A.Z, H2A.Z.2.2, severely destabilizes nucleosomes and that Uhrf2 dynamics depend on 
the methylation of H3K9. Emphasizing the methodological aspect of this work, it should be mentioned 
that we could also develop new strategies to label DNA sequences in living cells, characterize 
nanoparticles as vectors for nucleic acids and reveal hidden interactions of the cell cycle regulator 
nuclear interaction partner of anaplastic lymphoma kinase (NIPA). The continuous integration of 
microscopy developments in biological research will help in the future to dissect nuclear regulatory 




DNA-Methylierung ist ein essentieller Vorgang während der Entwicklung und die Erhaltung der DNA-
Methylierungsprofile ist äußerst wichtig für die korrekte Funktion der Zellen in Säugern. Die 
fehlerhafte Regulation dieses Vorgangs kann zur Entstehung von Krebs führen. Das entscheidende 
Protein ist die DNA-Methyltransferase 1 (Dnmt1), ein essentielles Protein, das die Methylierung an 
hemimethylierten CpG-Stellen nach der Replikation in der S Phase wiederherstellt. Zwei Dnmt1 
Domänen, die „proliferating cell nuclear antigen (PCNA) binding domain“ (PBD) und die „targeting 
sequence“ (TS) Domäne, sind verantwortlich dafür, dass Dnmt1 gezielt an Replikationsstellen und an 
konstitutives Heterochromatin gebunden wird. Allerdings ist die zellzyklusabhängige Funktionsweise 
und Regulation der Interaktionen immer noch unbekannt. Um die Regulation von Dnmt1 und anderen 
Faktoren im Kern zu verstehen, müssen deren Interaktionen nicht nur in vitro, sondern auch unter 
dynamischen in vivo Bedingungen untersucht werden. Moderne Fluoreszenzmikroskopie bietet eine 
Auswahl von Methoden, die uns erlauben in vivo Einblicke in die epigenetische Regulation zu erhalten. 
Aus diesem Grund haben wir begonnen die zellzyklusabhängige Dynamik von Dnmt1 zu analysieren. In 
unserem Ansatz haben wir die Methode „fluorescence recovery after photobleaching” (FRAP) mit 
kinetischen Modellen kombiniert und „3D-structured illumination microscopy“ ergänzend angewandt. 
Dieser Ansatz ermöglicht es detaillierte räumliche und zeitliche Informationen über die Dynamik von 
Dnmt1 und deren Regulation zu erhalten. Durch die Analyse von GFP-Dnmt1 Mutanten konnten wir 
zeigen, dass die Interaktionen, die durch die PBD und die TS Domäne vermittelt werden, sowohl 
notwendig, als auch ausreichend sind für die Lokalisation und die Dynamik von Dnmt1 in der S Phase. 
Mit Hilfe unseres maßgeschneiderten kinetischen Models konnten wir eine mittlere Interaktionszeit 
für die PBD mit PCNA von etwa 10 s und von der TS Domäne mit konstitutivem Heterochromatin von 
etwa 22 s ermitteln. Aufgrund dieser Ergebnisse stellen wir ein „two-loading-platform“ Modell auf, in 
dem PCNA und Heterochromatin als relativ stabile Plattformen während der S Phase betrachtet 
werden. In der frühen S Phase überwiegt die Bindung der PBD an PCNA. In der späten S Phase 
hingegen sind spezifischen Heterochromatin Bindestellen, an die die TS Domäne bindet, nahe der 
replizierenden Regionen. Dies führt zu einer starken Bindung, vermittelt durch die TS Domäne, die die 
Dnmt1 Dynamik in der späten S Phase dominiert. 
Darüber hinaus haben wir durch Fluoreszenzmikroskopie und biochemische Methoden ein tieferes 
Verständnis über die Funktion der Proteine Uhrf (“ubiquitin-like, containing PHD and RING finger 
domains“) 1, ein essentieller Faktor für die Aufrechterhaltung der DNA Methylierung, das homologe 
Protein Uhrf2 und der Histonvariante H2A.Z, beispielhaft für ein weiteres Level der epigenetischen 
Regulation, erhalten. Wir konnten zum Beispiel zeigen, dass eine alternative Splicevariante von H2A.Z, 
H2A.Z.2.2, Nukleosomen stark destabilisiert und dass die Uhrf2 Dynamik von der Methylierung von 
H3K9 abhängt. Der methodischen Aspekt dieser Arbeit wird außerdem durch die Entwicklung neuer 
Zusammenfassung 
V 
Strategien für die Markierung von DNA-Sequenzen in lebenden Zellen, die Charakterisierung von 
Nanopartikel  als Vektoren  für Nukleinsäuren und die Aufdeckung versteckter Interaktionen des 
Zellzyklusregulators „nuclear interaction partner of anaplastic lymphoma kinase“ (NIPA) betont. Der 
kontiniuierliche Transfer neuer Entwicklungen aus der Mikroskopie in die biologische Forschung wird 






1.1 Epigenetics  
Every human being develops from a single totipotent cell. The DNA sequence within this cell is 
replicated during each cell division leading to almost identical genetic information in all somatic cells 
of the body. However, our adult body consists of over 400 different cell types with diverse functions 
and morphology (Vickaryous and Hall, 2006). This large diversity is generated by cell type specific 
regulation of gene expression. Heritable information that directs these regulatory processes, but is not 
encoded in the DNA sequence, is summarized under the term epigenetics (epi, Greek: επί- over, 
above, outer). Epigenetic processes do not only play a major role in differentiation and development, 
but are also involved in cellular aging and the development of cancer (Hannum et al., 2013, Dawson 
and Kouzarides, 2012). Moreover, multiple diseases, apart from cancer, are linked to epigenetic 
factors and processes. Examples are single gene disorders, caused by mutations in genes coding for 
epigenetic factors, including the Rett syndrome or the ATRX syndrome (Feinberg, 2007). In addition, 
imprinted gene disorders are linked to epigenetics. Genomic imprinting describes the selective 
repression of either the paternally or maternally inherited allele by epigenetic mechanisms (Morison 
et al., 2005). Epigenetic alterations in genes or their control regions can lead to diseases, e.g. the 
Beckwith-Wiedemann Syndrome (Choufani et al., 2013). Recently, even common complex diseases 
like rheumatoid arthritis or epilepsy have been discussed in connection with epigenetics (Liu et al., 
2013b, Qureshi and Mehler, 2010). 
The classical definition of epigenetics reads: “The study of mitotically and/or meiotically heritable 
changes in gene function that cannot be explained by changes in DNA sequence” (Russo et al., 1996). 
This includes many diverse processes like the DNA methylation system, histone modifications, histone 
variants, nucleosome positioning and non-coding RNA (Figure 1). Accordingly, prions are included in 
this definition, as they are proteins that pass on their changes that are not based on DNA sequence 
(Halfmann and Lindquist, 2010). In addition to the modified DNA base 5-methylcytosin (5mC) the new 
DNA modifications 5-hydroxymethylcytosin (5hmC), 5-formylcytosin (5fC) and 5-carboxcytosin (5caC) 
have recently been discovered, forming a complex DNA modification system (Figure 1). Some of the 
epigenetic marks occur only for short time frames during the cell cycle and are therefore not 
classically heritable. Hence, a recent definition has shifted the focus more to chromatin structure: “… 
the structural adaptation of chromosomal regions so as to register, signal or perpetuate altered 
activity states.” (Bird, 2007). This chromatin structure-based definition paints a much more dynamic 




Figure 1: Epigenetic mechanisms. DNA can be methylated (mC), further oxidized to hmC, fC and caC or transcribed to non-
coding RNA. Further epigenetic mechanisms are nucleosome positioning, incorporation of histone variants or 
posttranslational modification of histones, e.g. methylation (me), acetylation (ac) or ubiquitination (ub). 
Chromatin structure and organization 
The structural basis of chromatin is a chain of basic single building units, called nucleosomes. In each 
nucleosome, 145-147 base pairs of DNA are wrapped around a histone octamer, consisting of two 
histone 2A and histone 2B  dimers (H2A-H2B) and a tetramer built up of two histone 3 and histone 4 
dimers (H3-H4)2 (Luger et al., 1997). The resulting 11 nm fiber is further compacted to the 30 nm fiber 
involving the linker histone H1 (Li and Reinberg, 2011), however, the presence of the 30 nm fiber in 
vivo is highly debated and details about the higher order chromatin structure still need to be 
investigated (Maeshima et al., 2010). In general, interphase chromatin is subdivided into open, 
transcriptionally active euchromatin and condensed, transcriptionally inactive heterochromatin (Politz 
et al., 2013). It has been proposed that euchromatic fibers harbor six nucleosomes per 11 nm, 
whereas the compaction increases in heterochromatin to a packing density of 11-12 nucleosomes per 
11 nm (Bassett et al., 2009). Furthermore, heterochromatin can be subdivided into constitutive and 
facultative heterochromatin. Both describe silent and compacted chromatin, but only facultative 
heterochromatin has the potential to switch to a more euchromatic state (Trojer and Reinberg, 2007). 
Constitutive heterochromatin is found at the telomeres, the centromere and at pericentromeric 
regions, all composed of DNA tandem repeats (Politz et al., 2013). In mouse cells, the centromeric 
region and the pericentromeric region mainly consist of minor satellite DNA and major satellite DNA, 
respectively (Probst and Almouzni, 2011). Not only the degree of packaging, but also the localization 
of chromatin domains in the nucleus affects gene expression. As a general rule, the chromatin at the 
nuclear periphery and around the nucleoli is rather gene poor and composed of silent 
heterochromatin, whereas the area in between is gene rich and composed of active euchromatin 
(Joffe et al., 2010). Prominent heterochromatic structures in mouse cells are the so-called 
chromocenters. In chromocenters, the pericentromeric regions of multiple chromosomes form tightly 
packed foci in the nucleus. The number and localization of chromocenters differs among cell types and 
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species and the clustering of heterochromatic domains could facilitate repression of repetitive 
sequence recombination and transposon silencing (Padeken and Heun, 2013, Cerda et al., 1999).  
Nucleosomal modifications and positioning 
Epigenetic mechanisms can change the higher order chromatin structure and thereby directly 
influence, for example, the accessibility of the DNA to transcription factors. Direct structural changes 
are created by altered charges, which form internucleosomal or intranucleosomal links. Modifications 
of the N-terminal tails of histones, or of the histone core are able to induce structural changes. 
Histones can be methylated, acetylated, phosphorylated, ubiquitinated, sumoylated, ADP-ribosylated 
or deiminated, amongst others (Kouzarides, 2007). For instance, acetylation of lysines neutralizes the 
positive charges of the histones and loosens the DNA-histone interaction in the nucleosome (Zentner 
and Henikoff, 2013, Shogren-Knaak et al., 2006). Combinations of histone modifications, often 
referred to as a histone code, can change chromatin structure to a larger extend by facilitating 
nucleosome sliding or repositioning (Cosgrove et al., 2004). Insertion, movement or removal of 
nucleosomes is carried out by so-called nucleosome remodelers. This process has been documented at 
the transcriptional start site resulting in nucleosome free regions (Zhang et al., 2011). Another 
mechanism to functionally alter chromatin structure is the incorporation of histone variants, which is 
further explained in chapter 1.3. Furthermore, some histone variants are differently modified at their 
N-terminal ends in contrast to the canonical histones, thus creating specific modifications with a 
potential impact on chromatin structure (Luger, 2006). Finally, there are indications that DNA 
methylation exerts a direct effect on nucleosome stability (Collings et al., 2013, Lee and Lee, 2012). 
Epigenetic readers, writers and erasers 
Histone modifications or DNA methylation can also indirectly influence chromatin structure and gene 
expression by activating or inactivating other proteins or pathways. In this case, the modifications act 
as signals for specific epigenetic reader proteins. These readers then recruit writers or erasers, 
establishing or removing new regulatory marks that directly change chromatin structure or trigger 
signaling cascades (Figure 2). Often, multiple epigenetic mechanisms act together within the 
regulatory networks. The establishment of heterochromatic sequences at pericentromeric 
heterochromatin in early development, for example, has been reported to require the interplay of 
non-coding RNA, histone modifications (H3K9me3) and DNA methylation (Cedar and Bergman, 2009). 
The role of epigenetic marks in signaling is especially interesting in the field of DNA methylation, as a 
whole new set of modifications and their writers, readers and erasers have been recently identified, 
which are further discussed in the next chapter. This discovery has raised many exiting questions and 





 Figure 2: Readers, writers and erasers of epigenetic modifications. DNA or histone modifications have to be established and 
maintained by writers and can be removed by erasers. In order to lead to a functional output, the marks have to be identified 
by specific readers that process these signals and activate or inactivate other proteins or pathways. 
1.2 DNA methylation 
DNA methylation is present in most species, including fungi, plants and animals. Interestingly, many 
model organisms like Drosophila melanogaster, Saccharomyces cerevisiae, Saccharomyces pombe and 
Caenorhabditis elegans have no or only low DNA methylation levels (Feng et al., 2010, Zemach et al., 
2010). In mammals, methylation of position 5 of cytosine (5mC) in a cytosine-phosphatidyl-guanine 
(CpG) context is the predominant DNA modification. Nevertheless, in embryonic stem cells (ESC) 
significant methylation levels in a CpA context have been detected (Ziller et al., 2011, Ramsahoye et 
al., 2000, Lister et al., 2009). In plants, methylation is found in many contexts, such as CG, CNG (N = 
A,C,T,G) and CHH (H= A, C, T) (Henderson and Jacobsen, 2007).  
In the mammalian genome, CpG sites are underrepresented possibly due to mutagenic pressure as 
5mC can be deaminated to thymidine, but a majority of 60-80% of these rare CpG sites are methylated 
(Smith and Meissner, 2013). Interestingly, DNA regions with a high density of CpG sites, called CpG 
islands are predominantly unmethylated (Bird et al., 1985). CpG islands are often located in promoters 
of housekeeping genes or genes that are regulated during development (Meissner et al., 2008). The 
high CG content due to the CpG density might facilitate their transcription (Moore et al., 2013). In 
contrast, methylation of CpG islands leads to stable silencing of the associated genes. However, the 
majority of CpG islands stays hypomethylated during development, whereas hypermethylation can be 
detected in cancer or aging (Richardson, 2003). Especially, CpG islands in promoter regions do not 
seem to play a role in tissue specific methylation. Tissue specific methylation rather correlates with 
the methylation status of CpG islands outside of promoter regions, so-called orphan CpG islands, 
which often include transcriptional start sites for long non-coding RNAs (Illingworth et al., 2010). 
Besides methylation at promoters and the first exon that usually results in transcriptional silencing, 
the role of methylation in gene bodies is still controversial (Brenet et al., 2011). Correlation with high 
gene expression has been reported, but cannot be found in slowly dividing cells (Aran et al., 2011). 
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Recently, a role of gene body DNA methylation in regulation of alternative promoters has been 
proposed (Maunakea et al., 2010). Besides this gene specific context, many non-coding repetitive 
sequences are methylated, including pericentromeric repeats and transposable elements (Smith and 
Meissner, 2013). DNA methylation is one of the mechanisms to keep these non-coding sequences 
compacted and silent in order to ensure genome integrity. 
In contrast to other epigenetic processes, DNA methylation is especially important in the persistence 
of silent epigenetic states. While other epigenetic processes, like histone modifications can be 
metaphorized as a door that is opened or closed, representing active or inactive chromatin regions, 
DNA methylation rather represents the key to the door locking the silent epigenetic state (Cedar and 
Bergman, 2009). The establishment of persistent silent epigenetic states by DNA methylation is not 
only important during embryonic development, but also during adult stem cell differentiation of the 
neural or hematopoietic lineage (Smith and Meissner, 2013). The most striking changes in DNA 
methylation levels occur during embryonic development. Global waves of demethylation occur during 
early embryogenesis and during the formation of the gametocytes in the embryo. Interestingly, the 
paternal genome is demethylated much faster compared to the maternal genome in the zygote and 
remethylation of the parental genome in the primordial germ cells also occurs on a shorter time frame 
(Seisenberger et al., 2013). The DNA methylation level changes are supposed to increase the 
epigenomic plasticity and to reset imprinted regions. 
Methylation of cytosine in mammals is catalyzed by the family of DNA methyltransferases (Dnmt). This 
family consists of 5 methyltransferases Dnmt1, Dnmt3a, Dnmt3b, Dnmt3L and Dnmt2 (Figure 3). 
Dnmt3a and Dnmt3b set the methylation marks de novo during embryogenesis assisted by the 
cofactor Dnmt3L (Moore et al., 2013). Knockout studies in mice reveal that Dnmt3b is required earlier 
in development compared to Dnmt3a, as knockout mice lacking Dnmt3b are not viable, whereas 
Dnmt3a knockout mice survive about 4 weeks after birth (Okano et al., 1999). Once the methylation 
marks are established, they are maintained by Dnmt1 during DNA replication and repair (Mortusewicz 
et al., 2005, Bird, 2002, Bestor, 2000). Dnmt2 lacks the N-terminal regulatory region and is structurally 
very similar to the bacterial DNA methyltransferase M.HhaI (Dong et al., 2001). It is still under 
discussion, whether the highly conserved Dnmt2 is capable of DNA methylation, but it has been 
reported that Dnmt2 is able to methylate tRNA promoting tRNA stability and protein synthesis 




Figure 3: Roles of DNA methyltransferases. Dnmt3a and Dnmt3b methylate CpG sites de novo during early embryogenesis 
assisted by the cofactor Dnmt3L. Dnmt1 fully methylates hemimethylated CpG sites during DNA replication and repair. 
Dnmt2 methylates tRNAs. Closed circles represent methylated, open circles unmethylated sites. 
How the target sites of de novo methylation are identified still remains unclear, but different 
mechanisms have been suggested (Moore et al., 2013, Smith and Meissner, 2013). Targeting could 
either occur by direct recruitment of Dnmts or by blocking of DNA sites that are supposed to be 
protected from methylation. In both cases, binding of transcription factors, RNAs, histone 
modifications, histone variants or a combination of multiple processes are likely to be involved. 
Furthermore, methylation marks can be removed actively or passively by a lack of maintenance. There 
has been a long search for demethylases, however, no enzyme that cuts the methyl group from 
cytosine has been discovered so far in mammals. Recently, there has been increasing evidence that 
the removal of methyl groups occurs via another pathway. It has been discovered that the ten-eleven- 
translocation (Tet) proteins oxidize 5-methylcytosin (5mC) to 5-hydroxymethylcytosin (5hmC) and 
further to 5-formylcytosin (5fC) and finally to 5-carboxcytosin (5caC) (Ito et al., 2011, Tahiliani et al., 
2009). The new DNA bases, especially 5hmC might not be recognized by Dnmt1 and therefore lead to 
passive demethylation (Hashimoto et al., 2012). Active demethylation probably includes DNA repair 
mechanisms. 5fC and 5caC are, for example, recognized by the thymine-DNA glycosylase (TDG) 
followed by base excision repair (BER) (Shen et al., 2013). Alternatively, the AID (activation induced 
cytidine deaminase) and APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like) 
family enzymes can deaminate 5hmC to 5-hydroxyuracil (5hmU) which is recognized by the BER 
pathway (Guo et al., 2011). Moreover, the new bases might not only be intermediates during removal 
of methylation, but also act as signals detected by specific readers influencing gene expression. 
Recently, a study has identified readers of 5hmC, 5fC and 5caC in comparison to 5mC readers (Spruijt 
et al., 2013). Specific readers for each modification were identified and the interactions with 5mC and 
5hmC were shown to change during differentiation, giving first hints towards the functional 
significance of the newly discovered DNA bases.  
The readers of the classical 5mC marks are termed methyl-CpG-binding proteins (MBP) and can be 
categorized in three groups, namely proteins containing either (1) a methyl-CpG-binding domain 
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(MBD), or  (2) a zinc finger (ZnF; Cys2His2) domain or (3) proteins that are ubiquitin-like, containing 
PHD and RING finger domains (Uhrf) (Buck-Koehntop and Defossez, 2013). In general, the MBPs 
influence chromatin organization or transcriptional activity directly or indirectly by recruiting other 
factors (Fournier et al., 2012). The majority of the MBPs mediate crosstalk between DNA methylation 
and other epigenetic processes like histone modifications. For instance, MeCP2, an MBD protein, binds 
methylated DNA and recruits histone deacetylases (HDAC) leading to transcriptional repression (Nan 
et al., 1998). Further MBD proteins are MBD1, MBD2, MBD3, MBD4, MBD5 and MBD6 of which MBD1, 
2 and 4 bind methylated DNA, whereas MBD 3, 5 and 6 are excluded from methylated DNA  (Buck-
Koehntop and Defossez, 2013). Similar to MBD proteins, many ZnF proteins bind methylated DNA in a 
sequence-specific context (Buck-Koehntop and Defossez, 2013). Uhrf1 has a strong affinity for 
hemimethylated sites and is able to bind Dnmt1 and target it to them. The Uhrf family will be 
discussed in detail in chapter 1.2.3.  
Misregulation of DNA methylation is a hallmark of cancer development. Tumor cells are characterized 
by global hypomethylation and local hypermethylation at CpG islands (Berman et al., 2012). 
Hypomethylation of repetitive sequences causes genomic instability, whereas hypermethylation at 
promoters of tumor suppressor genes enhances cell proliferation and reduces levels of apoptosis 
(Portela and Esteller, 2010, Esteller, 2011). One successful strategy of cancer treatment has been the 
chemotherapeutic agent 5-aza-desoxycytidine that covalently links Dnmts to DNA thereby inhibiting 
their function. Since 2004, 5-aza-dC has been approved as a drug against myelodysplastic syndrome 
(Kaminskas et al., 2005).  
1.2.1 Dnmt1 
The regulation and the molecular mechanism of Dnmt1 has been a popular field of research for many 
years. The knockout of Dnmt1 in mice is recessive embryonic lethal before embryonic day 11 (Li et al., 
1992). Surprisingly, the corresponding ESCs are still viable containing DNA methylation levels reduced 
by about two thirds. In MEF cells, the knockout leads to p53-induced apoptosis that can be overcome 
by depletion of p53 (Lande-Diner et al., 2007). 
Dnmt1 is composed of a C-terminal catalytic domain and a large N-terminal regulatory region 
connected by a linker consisting of several alternating lysine-glycine (KG) repeats (Figure 4). In contrast 
to bacterial methyltransferases, the catalytic domain alone is not active (Cheng, 1995, Margot et al., 
2000), demonstrating that the regulation by the N-terminal domain is essential for the activity of 
mammalian Dnmt1. However, a truncation of half of the N-terminal domain is still catalytically active 
(Jeltsch, 2006). In line with this, the first 118 amino acids of the N-terminus missing in an oocyte 
specific isoform of Dnmt1 are dispensable for proper enzyme function. This region contains a domain 
binding to the Dnmt1-associated protein 1 (DMAP1) and is supposed to function in transcriptional 
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repression (Rountree et al., 2000). Nuclear import of Dnmt1 is achieved by at least one nuclear 
localization signal (NLS) located in the N-terminal region (Cardoso and Leonhardt, 1999). 
 
Figure 4: Dnmt1 domain architecture. The protein consists of a C-terminal catalytic domain and an N-terminal regulatory 
region interconnected by a linker. The domains in the regulatory region include the DMAP, the PBD, a NLS, the TS domain, a 
CXXC domain and two BAH domains.  
This work focuses on two domains of Dnmt1, namely the protein proliferating cell nuclear antigen 
(PCNA)-binding domain (PBD) and the targeting sequence (TS) domain. The PBD mediates the 
transient interaction with PCNA and is not essential for the catalytic reaction, but enhances the 
methylation efficiency about 2-fold (Schermelleh et al., 2007, Chuang et al., 1997). PCNA forms a 
trimeric ring around the DNA and interacts with a large number of proteins, serving as a loading 
platform during replication and repair (Moldovan et al., 2007). The second domain mediating cell 
cycle-dependent targeting of Dnmt1, the TS domain, targets Dnmt1 to constitutive heterochromatin 
(Easwaran et al., 2004, Leonhardt et al., 1992). Furthermore, the TS domain has been implicated in 
several other interactions or mechanisms. A bipartite interface within the TS domain was found to be 
responsible for dimerization of Dnmt1 (Fellinger et al., 2009) and the TS domain was also reported to 
mediate the interaction with Uhrf1 (Frauer and Leonhardt, 2011, Achour et al., 2008, Felle et al., 
2011b, Bashtrykov et al., 2013). The crystal structure of Dnmt1 hints at an autoinhibitory role of the TS 
domain, where the TS domain has to be unfolded from the catalytic domain in order to allow binding 
of 5mC (Takeshita et al., 2011). 
A similar autoinhibitory role was proposed for the CXXC domain, localized downstream of the TS 
domain (Song et al., 2011). The CXXC domain can bind to unmethylated CpG sites, however, its 
function is still under discussion as it has been reported that it is dispensable for maintenance 
methylation (Frauer et al., 2011, Bestor, 1992). The polybromo homology domain (PBHD) (Liu et al., 
1998) containing two bromo adjacent homology (BAH) domains, thought to mediate protein-protein 
interactions involved in gene silencing (Jurkowska et al., 2011). It has been reported that the PBHD 
interacts with the ubiquitin carrier protein (Ubc) 9, which sumoylates Dnmt1, leading to an enhanced 
catalytic activity of Dnmt1 (Lee and Muller, 2009), but the detailed function of the PBHD remains 
unclear. As a further regulatory mechanism, an interaction between the C- and the N-terminus seems 
to be required for the catalytic activity of Dnmt1 (Margot et al., 2003). The enzymatic reaction of 
Dnmts involves the formation of a covalent complex between the C6 position of the cytosine ring and 
the sulfhydryl group of the cystein in the conserved PC motif of the catalytic domain (motif IV). 
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Thereafter, the methyl group is transferred from the donor S-adenosyl-L-methionine (SAM) to the C5 
of the cytosine, followed by the release of the Dnmt by β elimination (Goll and Bestor, 2005).  
Dnmt1 is ubiquitously expressed in various tissues, but increased levels of Dnmt1 have been detected 
in many cancers (Peng et al., 2005, Saito et al., 2003, Robertson et al., 1999). Given that alterations of 
Dnmt1 expression levels can lead to malignancies, it is important that protein expression, stability and 
activity are tightly controlled. One mechanism controlling Dnmt1 abundance is the ubiquitination of 
Dnmt1 by Uhrf1 leading to proteasomal degradation of Dnmt1 (Du et al., 2010, Qin, 2011). The 
ubiquitination of Dnmt1 is triggered by acetylation of Dnmt1 by Tat-interactive protein 60 (Tip60). In 
contrast, Usp7 and HDAC1 protect Dnmt1 from degradation by deubiquitination and deacetylation of 
Dnmt1, respectively. Dnmt1 expression is, for instance, regulated by the Ras-AP-1 and the pRb-E2F 
signaling pathways (Rouleau et al., 1995, McCabe et al., 2005).  
1.2.2 Coupling of maintenance methylation to the cell cycle 
The abundance of Dnmt1 is not only regulated during differentiation, but also during cell cycle 
progression. The protein amounts are highest in S phase and start to decrease in late S phase or G2 
with lowest levels in G1 (Du et al., 2010, Vogel et al., 1988). Besides cell phase specific expression 
levels of Dnmt1, the interaction with important binding partners also ensures faithful maintenance 
methylation of replicated DNA. For instance, the interaction of Dnmt1 with PCNA via the PBD, couples 
the localization of Dnmt1 tightly to DNA replication.  
In somatic mouse cells, at least three stages of replication are clearly distinguishable by replication 
markers like PCNA or nucleotide analogues like bromodeoxyuridine (BrdU) or ethynyldeoxyuridine 
(EdU). The cells pass from early to mid and then to late S phase (Figure 5) (Somanathan et al., 2001, 
Dimitrova and Berezney, 2002, Leonhardt et al., 2000, Goldman et al., 1984). In early S phase, 
euchromatic regions are replicated leading to a pattern of multiple small foci distributed in the 
nucleus, but excluded from the nucleoli and the nuclear periphery. In mid S phase, an enrichment of 
replication foci at the nuclear periphery and around nucleoli is observable. In mid S Phase replication 
foci, facultative heterochromatin is replicated, followed by replication of constitutive heterochromatin 
in late S phase. In mouse cells, constitutive heterochromatin clusters in chromocenters, resulting in 
large horseshoe-shaped replication foci upon heterochromatin replication. The molecular mechanism 
of the chromatin-dependent replication timing is not yet fully investigated, but there are indications 
that it is created by a stochastic process. The prerequisites for this so-called relative efficiency model 
are an increasing efficiency of origin of replication activation over time and more efficient  firing of 
some origins of replication, thus creating an asynchronous process (Rhind, 2006). The latter could be 
created by different compaction states of chromatin that regulate the accessibility of origins and 
thereby influence the firing efficiency. The domino effect model states that replication affects the 
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surrounding chromatin structure, leading to an increased firing efficiency of origins in close proximity 
to already replicating regions (Sporbert et al., 2002). The influence of chromatin compaction on 
replication timing is supported by the finding that histone acetylation can lead to a shift towards 
earlier replication timing (Kemp et al., 2005, Casas-Delucchi et al., 2012). Furthermore, the replication 
timing of 20% of the genome changes during ESC differentiation, in line with the fact that loci specific 
chromatin compaction is drastically altered during differentiation (Hiratani et al., 2008). 
 
Figure 5: Cell cycle-dependent localization of GFP‐Dnmt1wt and RFP‐PCNA in mouse fibroblast cells. Replication sites are 
marked by RFP-PCNA (red). GFP‐Dnmt1 (green) displays a diffuse nuclear distribution in G1 and association with replication 
sites in early to mid S phase. In late S phase, GFP-Dnmt1 associates strongly with constitutive heterochromatin at 
chromocenters of mouse cells which persists into G2 phase.  
Dnmt1 largely colocalizes with the replication pattern observed for PCNA during early and mid S 
phase. However, at the end of late S phase, a part of the Dnmt1 population remains associated with 
the chromocenters although replication progresses further. At the onset of G2 Dnmt1 is still enriched 
at constitutive heterochromatin. There are two possible explanations for this phenomenon. Dnmt1 
either completes the DNA methylation at the densely methylated heterochromatic regions or Dnmt1 
acts as an anchor for further processes (Easwaran et al., 2004).  
1.2.3 Uhrf1 and Uhrf2 
Interaction with PCNA causes enrichment of Dnmt1 at hemimethylated sites, but a second mechanism 
targets Dnmt1 directly to hemimethylated sites via interaction with the protein Uhrf1 (also known as 
Np95 or ICBP90). This became apparent in 2007, when it has been discovered that the knockout of 
Uhrf1 leads to reduced DNA methylation levels, mimicking the phenotype of the Dnmt1 knockout in 
mice (Bostick et al., 2007, Sharif et al., 2007). One year later, structural studies reported that Uhrf1 
binds to hemimethylated CpG sites by flipping out the methylated cytosine base (Arita et al., 2008, 
Avvakumov et al., 2008, Hashimoto et al., 2008). Based on these results, the model proposed, that 
Uhrf1 targets Dnmt1 to hemimethylated sites in the DNA sequence, although Dnmt1 seems to have an 
intrinsic preference for hemimethylated DNA (Bashtrykov et al., 2012, Frauer and Leonhardt, 2009). 
Furthermore, the ability of Uhrf1 to bind histone modifications provides a link between histone 
modifications and DNA methylation (Rottach et al., 2010, Liu et al., 2013a, Rothbart et al., 2012).  
Introduction 
11 
Uhrf1 is a multidomain protein, composed of an ubiquitin-like (Ubl) domain, a tandem tudor domain 
(TTD), a plant homeodomain (PHD), a SET (Suv39, Enhancer-of-zeste, Trithorax) and RING associated 
(SRA) domain and a really interesting new gene (RING) domain (Figure 6). The SRA domain mediates 
the interaction with hemimethylated DNA, whereas the TTD and the PHD mediate the interaction with 
histone modifications. The TTD, together with the PHD, selectively bind to H3K9me3. H3K9me3 is a 
repressive mark, characteristic for constitutive heterochromatin, set by the methyltransferases 
Suppressor of Variegation (Suv)39h1 and Suv39h2 (Peters et al., 2001). Uhrf1 is a member of the 
RING-finger type E3 ligase family. Typically, the RING-finger type E3 ligases are involved in the 
ubiquitination pathway and indeed the RING domain enables Uhrf1 to ubiquitinate Dnmt1 leading to 
the proteasomal degradation of Dnmt1 (see 1.2.1). In addition, Uhrf1 harbors an Ubl domain at the N-
terminus. This domain might be involved in the proteasomal degradation pathway, but its function has 
not been fully elucidated yet (Bronner et al., 2013).  
 
Figure 6: Uhrf1 and Uhrf2 domain architecture and homology. Uhrf1 and Uhrf2 contain a Ubl domain, a TTD, a PHD, a SRA 
domain and a RING domain. The homology based on the primary protein sequence between the domains in both proteins is 
depicted in percent. 
Similar to Dnmt1, Uhrf1 is upregulated in many cancers and, hence, considered to be a marker or a 
potential target for cancer therapies (Mousli et al., 2003, Unoki et al., 2009). Furthermore, Uhrf1 is 
constitutively expressed during the cell cycle in cancerous cell lines, in contrast to a peak in expression 
in late G1 and at the G2/M transition in non-cancerous cell lines (Mousli et al., 2003).  
The second member of the Uhrf family is Uhrf2 (also known as Np97 or NIRF). Uhrf2 shows a 
remarkable structure and even sequence conservation to Uhrf1 (Bronner et al., 2007, Pichler et al., 
2011). However, there are some differences between the two proteins, especially in the TTD (Figure 
6). Uhrf2 has been reported to be involved in the degradation of nuclear protein aggregates (Iwata et 
al., 2009), but it is not clear whether Uhrf2 has a functional role in DNA methylation. Therefore, a 
highly interesting question is thus whether the two proteins are functionally redundant or whether 
Uhrf2 possesses a distinct role. 
1.3 Epigenetic regulation by histone variants  
Besides DNA methylation and histone modifications, the importance of histone variants in the context 
of chromatin structure and gene expression has become more and more evident. Histone variants are 
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important for many processes, such as DNA repair, transcriptional regulation and epigenetic 
reprogramming (Bernstein and Hake, 2006). The incorporation of histone variants changes epigenetic 
states either directly or indirectly by recruiting different reader proteins through a variety of 
mechanisms. For instance, some histone variants harbor specific sites that can be differently modified 
compared to canonical histones or introduce structural changes facilitating nucleosome sliding or 
eviction by changing the histone-DNA or histone-histone interfaces (Luger, 2006).  
Canonical histones are only expressed in S phase, they are encoded in gene clusters that do not 
contain introns and the mRNA is characterized by a 3’-stem loop, which is not polyadenylated. These 
characteristics are, however, not found for histone variants, which are differently regulated, expressed 
throughout the cell cycle, contain introns and have a polyadenylated mRNA (Marzluff et al., 2008). The 
incorporation and eviction of histone variants is promoted by specific chaperones (Park and Luger, 
2008). For example, the exchange of H2A-H2B with H2A.Z can be catalyzed by the complex 
p400/NuA4/Tip60 (E1A-binding protein p400/nucleosomal acetyltransferase of H4/Tat-interactive 
protein 60) or by SRCAP (Snf2-Related CREBBP activator protein) (Billon and Cote, 2012). In 
nucleosomes always two copies of every histone are present. Therefore, either one or both histones 
of one type can be exchanged with variants. Furthermore, different histone variants can be combined 
in one nucleosome, leading to a great number of possible nucleosome compositions. 
So far, variations of the core histones H2A, H2B and H3 have been identified in mammals. The largest 
family of variants has been described for H2A (Figure 7). A well known variant is H2A.X, which is 
phosphorylated at serine 139, if DNA double strand breaks occur (γH2A.X) and facilitates the DNA 
repair process (van Attikum and Gasser, 2005). Another example is macroH2A that is incorporated to a 
great extend into the inactive X chromosome and is involved in the transcriptional repression on this 
chromosome and also on autosomes (Gamble and Kraus, 2010). The histone variants H2A.BBD (bar 
body deficient) and H2A.Z are related to chromatin stability. H2A.BBD is only detected in mammals 
and has been reported to be involved in spermatogenesis. Furthermore, the incorporation of H2A.BBD 
in somatic cells has been shown to destabilize the nucleosome (Gautier et al., 2004).  
H2A.Z is conserved between different species and is essential in mouse, drosophila and xenopus 
(Bonisch and Hake, 2012). It is, hence, not surprising that this variant functions in a variety of 
processes including transcriptional regulation, DNA repair, heterochromatin formation, chromosome 
segregation and mitosis (Bonisch and Hake, 2012). Based on the various functions regarding chromatin 






Figure 7: Schematic representation of human H2A variants. In contrast to the canonical H2A, H2A.X harbors a special C-
terminal region prone for phosphorylation and macroH2A contains a large macro domain at the C-terminus. The C-terminal 
region is also specific in H2A.Z, whereas H2A.BBD lacks the C-terminal domain and has an N-terminal domain that is distinct 
from the other H2A variants. 
1.4 Spatial and temporal dynamics of nuclear processes 
1.4.1 Nuclear protein dynamics 
Most of the processes and interactions, which have been introduced in the previous chapters, are 
highly dynamic. With the start of this century it became clear that many of the interactions thought to 
be highly stable are indeed very transient (Phair and Misteli, 2000). For instance, a lot of chromatin-
binding proteins like HP1 or even the histone H1 constantly bind and unbind their target (Stasevich et 
al., 2010, Schmiedeberg et al., 2004, Cheutin et al., 2003). Apparently, chromatin, including the 
canonical core histones, provides a relatively stable framework, where other proteins transiently bind 
to. Further stable proteins are located in the nuclear lamina such as lamin A and lamin B or 
nucleoporins like NUP153 (Xu and Powers, 2013, Moir et al., 2000). Furthermore, several nuclear 
compartments not enclosed by a membrane, appear as relatively stable regions in the nucleus. These 
nuclear compartments include nucleoli, nuclear speckles, replication foci, PML bodies and Cajal bodies 
(Spector, 2001) and they are to some extend dynamic. For example, the spatial distribution of 
replication foci changes in a complex pattern during S phase (see 1.2.2). The proteins in the replication 
complexes are continuously exchanged. Furthermore, nuclear compartments could be self-assembling 
or self-organizing complexes that are created by accumulation of specific factors binding to each other 
with high affinity (Hemmerich et al., 2011).  
Regarding the question of how proteins find their target, a theory states that many nuclear factors 
passively diffuse through the crowded nucleus in order to find their target in a kind of a random-
scanning mechanism (Gorski et al., 2006). As diffusion of small molecules is very fast in the range of 
30-80 µm²/s (Braga et al., 2004), this random-scanning mechanism, in combination with transient 
binding events, could be a fast and energy efficient way to target proteins. Furthermore, this 
combination allows a very fast reaction to external factors without the need of guided unbinding of 
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chromatin factors. Fine-tuning the strength of association and dissociation rates in combination with 
the abundance of proteins, contribute to the creation of nuclear organization (Hemmerich et al., 
2011). In essential cellular processes, chaperones aid the assembly of nuclear components (Ellis, 
2006). PCNA, for instance, forms a trimeric ring around DNA and is loaded onto DNA by the chaperone 
replication factor C (RFC) (Indiani and O'Donnell, 2006). After loading to DNA, the complex slides along 
DNA in one dimension. The dynamic landscape in the nucleus seems to be necessary to provide 
stability as well as plasticity in the cell (Misteli, 2001). A goal of this work is the analysis of the 
temporal and spatial kinetics of this nuclear dynamic landscape. Therefore, there is an increasing need 
for methods that do not only provide a snapshot of the current state, but allow insights into the 
dynamic interplay of proteins. A very effective technique is advanced fluorescence microscopy. 
1.4.2 Fluorescence microscopy techniques to study epigenetic processes in vivo 
The field of fluorescence microscopy has been rapidly growing in the last two decades. The availability 
of high speed microscopes in combination with fluorescent proteins like the green fluorescent protein 
(GFP) has created a variety of methods. The so-called F-techniques include fluorescence recovery after 
photobleaching (FRAP), fluorescence loss in photobleaching (FLIP), Förster resonance energy transfer 
(FRET), fluorescence lifetime imaging microscopy (FLIM) and fluorescence correlation spectroscopy 
(FCS) (Ishikawa-Ankerhold et al., 2012). The F-techniques are complemented by single particle tracking 
(SPT) (Siebrasse et al., 2007). Furthermore, a variety of correlation spectroscopy methods related to 
FCS like raster scan image correlation spectroscopy (RICS) have been developed (Digman and Gratton, 
2012).  
Initially, FRAP was developed to investigate the lateral movement of membrane proteins (Axelrod et 
al., 1976), but it was later also used for kinetic analysis of intracellular as well as nuclear proteins. The 
techniques FRAP and FLIP exploit the fact that a fluorescent molecule, fused to the protein of interest, 
can be irreversibly bleached by a strong laser pulse. Fluorescent proteins in a cell appear in a dynamic 
equilibrium. After bleaching a distinct region or spot in a FRAP experiment this equilibrium is disturbed 
and diffusion of the bleached and unbleached proteins within the compartment can be visualized 
(Figure 8). Dependent on their mobility, the molecules restore the steady state equilibrium of the 
fluorescence distribution. The mobility of the proteins is dependent on their size and their specific or 
unspecific interactions with other molecules (van Royen et al., 2009). The fluorescence intensity in the 





Figure 8: Recovery of the fluorescence after bleaching half of the nucleus. C2C12 cells expressing GFP-Dnmt1 in early S 
phase. The bleached region is indicated as a rectangle around the left half of the nucleus. Recovery is reached after about 50 
s. Scale bar: 5 µm. 
In contrast to FRAP, in a FLIP experiment a region in a specific compartment is repeatedly bleached 
over time and the fluorescent intensity in an unbleached compartment or region is measured (Figure 
9). The advantage of the latter approach is that no damage by bleaching is induced in the observed 
area. Furthermore, the exchange of molecules between different compartments can be easily 
analyzed. In this way, for example, the rate of nucleocytoplasmic shuttling is measured (Koster et al., 
2005). FLIP is complementary to FRAP experiments as it adds the possibility of visualizing the immobile 
protein fraction in the cell. Specialized techniques like microirradiation are used to analyze the 
dynamic involvement of proteins in DNA repair (Figure 9). In microirradiation experiments, DNA 
damage sites are created with a strong UV laser in living cells to visualize the accumulation of tagged 
proteins to the DNA damage sites (Mortusewicz et al., 2007). A specialized variation of FRAP for the 
analysis of DNA methylation is the trapping assay (Schermelleh et al., 2005). This method uses the 
covalent attachment of the methyltransferases to its target sites in the DNA by incorporation of the 
nucleotide analog 5-aza-dC in S phase. The degree of immobilization of Dnmts can be measured by 
FRAP experiments (Figure 9). If Dnmt1 is highly active, many Dnmt1 molecules will be trapped by 
5-aza-dC, leading to a large immobile fraction after a short time frame. 
Kinetic modeling of FRAP data allows the estimation of diffusion coefficients and even binding rates of 
the analyzed proteins. FRAP has major advantages in contrast to in vitro techniques like binding assays 
with fluorescently labeled proteins or surface plasmon resonance (SPR). First, as it is an in vivo method 
it allows for the observation of the protein in near native conditions. In addition, a compartment and 
cell cycle-dependent approach is possible to temporally and spatially characterize the mobility of a 
protein. However, interactions are only indirectly characterized by comparing kinetics of the wild type 
protein with its mutants or with knockout cell lines. 
In order to get deeper insights into protein binding properties and functions, not only the temporal 
dynamics, but also the spatial changes have to be analyzed. Maximizing resolution is a major goal and 
major breakthroughs have been achieved in the last decades. The main techniques to overcome the 
resolution limit of about 200 nm in conventional light microscopy are 3D structured illumination 
microscopy (3D-SIM), stimulated emission depletion (STED) and a variety of localization microscopy 
methods like direct stochastic optical reconstruction microscopy (STORM) or photoactivated 
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localization microscopy (PALM) (Schermelleh et al., 2010). Among these techniques, 3D-SIM is 
especially suitable for super-resolution images in the nucleus, because the high axial resolution is not 
limited to total internal reflection fluorescence (TIRF) setups. Furthermore, it is possible to acquire 
images in three colors, allowing a comparison of the detailed localization of up to three different 
molecules. 
 
Figure 9: Bleaching techniques to determine the mobility of molecules in living cells. In FRAP experiments, a region in the 
cell is bleached and the recovery is measured over time. In FLIP experiments, a region is repeatedly bleached and the loss of 
fluorescence in another region or compartment is analyzed. During microirradiation, DNA damage is induced by a UV-laser 
and the recruitment of proteins to this area is analyzed. Therefore, if the protein is enriched, the relative intensity rises to 
values larger than one. In the specialized trapping assay, Dnmts are covalently bound to 5-aza-dC in the DNA. After addition 
of 5-aza-dC, it is incorporated into DNA in S phase and active Dnmt1 is trapped, leading to a decreased mobile fraction of 
Dnmts in FRAP experiments (black: without 5-aza-dC, red: with 5-aza-dC). 
1.4.3 Labeling and transfection strategies 
The investigation of nuclear processes is further challenged by the labeling of the structure or protein 
of interest and the delivery of the labeled molecules into the cell. 
Labeling of the designated proteins, protein modifications, DNA or RNA sequences or single bases 
provides the basis for the imaging methods that have been described before. Apart from standard 
techniques like immunofluorescent labeling with antibodies in fixed cells or fluorescent tagging of 
proteins with GFP or other fluorescent proteins, a wide range of specialized techniques has been 
developed. For instance, nanobodies, small functionalized camelid antibodies, are currently used to 
label proteins or modifications in living cells (Romer et al., 2011). Alternatively, short labeled Fab 
antibody fragments can be injected into living cells or small GFP-tagged domains like the MBD can be 
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used to detect DNA modifications like 5mC (Kimura et al., 2010). Another challenge is the specific 
labeling of DNA sequences. Besides existing methods like polydactyl zinc finger proteins (PZF) 
(Lindhout et al., 2007), a new approach exploits the designer transcription activator-like effectors 
(dTALE). TAL effectors are injected from pathogenic Xanthomonas bacteria into plant cells in order to 
activate gene expression in their host, facilitating bacterial survival and proliferation  (Mak et al., 
2013). Binding to specific DNA sequences is achieved by the central DNA-binding domain, containing 
tandem amino acid repeats that differ by repeat-variable-diresidues (RVD). The code, which RVDs 
detect each of the four nucleotides in DNA, has been unraveled and has since then allowed for the 
construction of dTALEs binding to user-defined sequences (Boch et al., 2009, Moscou and Bogdanove, 
2009). By expression of fluorescently tagged dTALEs, DNA sequences can be labeled specifically and 
their temporal and spatial distribution can be monitored in living cells. The application of dTALEs for 
sequence specific DNA labeling has, thus, been demonstrated and characterized in this work. 
Besides labeling nuclear structures, a second challenge is the delivery of nucleic acids (DNA, RNA) and 
proteins to the cells. Typically, specific gene expression vectors are transferred into cells with the help 
of cationic lipid reagents resulting in the synthesis of the encoded proteins in the cells. However, large 
complex proteins like antibodies are often inefficiently folded or assembled and transfer of purified 
proteins into cells often leads to endosomal entrapment of the proteins or high cell toxicity (Mellert et 
al., 2012). Therefore, new strategies need to be developed. Highly tunable transfer vectors are 
mesoporous silica nanoparticles (Cauda et al., 2009, Rathousky et al., 2004). They are taken up by 
mammalian cells via endocytosis or pinocytosis (Slowing et al., 2008). Introduction of various internal 
or external chemical functional groups can optimize their properties like biocompatibility, cellular 
uptake or the capability of loading and releasing molecules (Giri et al., 2007). For example, the 
functionalization of the nanoparticle surface with protoporphyrin IX increases the cellular uptake of 
nanoparticles and their release from the endosome upon illumination with UV light (Schlossbauer et 
al., 2012). Mesoporous silica particles are not only an effective research tool, but they also have a 
potential in medical applications. At the moment, the development of strategies to deliver drugs to 
specific tissues in the human body is an emerging field of research. Functionalized nanoparticles could 
be a way to bring the drug to a specific region, allowing release only in the target area (Mai and Meng, 
2013). 
1.5 Aims of this work 
Although many nuclear processes have been studied extensively, the majority of the results only 
represent snapshots in the dynamic and complex interplay of large regulatory networks. Therefore, 
the aim of this work was to get deeper insights into the spatio-temporal dynamics of nuclear proteins 
with a major focus on Dnmt1.  
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At first, I set out to dissect the cell cycle-dependent dynamics of Dnmt1. To address this question, I 
performed FRAP experiments with GFP-Dnmt1wt and a set of mutants to analyze the role of the PBD 
and the TS domain during different stages of the cell cycle with high temporal resolution. By applying a 
tailored kinetic modeling approach, I tried to decipher the specific mean residence times for the 
different interactions and the corresponding fractions of interacting molecules. Furthermore, using 
3D-SIM super-resolution microscopy, I wanted to gain further information about the localization of 
Dnmt1 in late S phase with high spatial resolution and correlate it with the findings about Dnmt1 
dynamics. As Uhrf1 is the potential binding partner of the TS domain-mediated interaction and has an 
essential role in DNA methylation, I also aimed at obtaining more information about Uhrf1 and at 
studying the differences between Uhrf1 and its homologue Uhrf2. 
Furthermore, I wanted to further develop our FRAP approach and apply it to other nuclear proteins 
like the histone variant H2A.Z or the cell cycle regulator nuclear interaction partner of anaplastic 
lymphoma kinase (NIPA). In addition, I tried to find tools that facilitate the analysis of nuclear 
dynamics and processes. Therefore, I have set out to exploit dTALEs for the labeling of DNA sequences 
in living cells and to characterize mesoporous silica nanoparticles, which can be used to transfer 
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Abstract 
NIPA (nuclear interaction partner of ALK) is an F-box-containing protein that defines a nuclear SCF-
type ubiquitin ligase (SCFNIPA), which targets nuclear cyclin B1 for ubiquitination and proteasomal 
degradation, thereby contributing to the timing of mitotic entry. Here we show that NIPA is localized 
to the nucleoplasmic site of the nuclear pore complex (NPC). Interestingly, we identified the 
nucleoporin TPR as a scaffold protein, which forms a very stable interaction with NIPA at the NPC. The 
C3HC zinc-finger motif located in the N-terminus of NIPA is responsible for the interaction with the 
nucleoporin TPR and disruption of this domain leads to mislocalization of NIPA from the NPC to the 
nuclear interior.  Moreover, inactivation of TPR by RNAi results in destabilization and subsequent 
degradation of NIPA. Based on the localization of the F-box protein at the inner site of the nuclear 
pore, we propose an intriguing mechanism for cyclin B1 degradation, through formation of a “cyclin 
trap” directly at the gate, targeting the substrate for ubiquitination just upon entry to the nucleus.  
Introduction 
Subcellular compartmentalization of the cell by membrane systems allows for the separation of 
essential processes. As a result, the transport of material between those compartments is crucial to 
maintain proper cellular functions. The passive and active nucleocytoplasmic transport through the 
doublelipid bilayer of the nuclear envelope is regulated by the nuclear pore complexes (NPCs), large 
multiprotein gateways composed of several copies of  30 different nucleoporins (NUPs)1,2.  
NPC architecture is based on the octagonal symmetry with distinct, structured subunits: cytoplasmic 
and nuclear coaxial rings placed on the periphery of outer and inner nuclear membrane, respectively; 
the main translocation channel is formed of eight elongated structures termed spokes and connects 
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both coaxial rings thereby also forming a spoke ring; peripheral NPC components, such as short, 
cytoplasmic filaments emanating towards the cytoplasm and filaments forming the nuclear basket 
converging into the distal ring 3-7. The nuclear basket, also called a “fish trap”, can facilitate 
interactions between transport complexes and serves as a docking site during cargo translocation8-10. 
The central architectural element of the nuclear basket is constituted by the translocated promoter 
region (TPR), which is anchored to the NPC by NUP15311,12. TPR is a 267-kDa protein of a bipartite 
structure: a large N-terminal domain forming a double coiled-coil and a nonhelical, highly acidic C-
terminal domain, not dominated by a particular type of secondary structure13,14. Besides its structural 
role in the assembly of the nuclear basket, TPR has been shown to be involved in mRNA export 
control15,16, activation of the met oncogene17, nuclear protein export18,19 as well as spindle checkpoint 
control20,21 and ERK2 nucleo-cytoplasmic translocation22, thus demonstrating multifunctional 
properties of the NPC. Additionally, recent studies point towards the involvement of NPC components 
in DNA damage repair23,24, regulation of both transcription25,26 and autophagy27 as well as in 
posttranslational modification with small ubiquitin-related modifier (SUMO) proteins28-30, suggesting a 
prominent role for the nuclear periphery in cellular physiology.  
We previously identified NIPA (nuclear interaction partner of anaplastic lymphoma kinase) as an F-
box-like protein, which together with SKP1/CUL1/ROC1 defines the SCFNIPA complex as a family 
member of the SCF-type ubiquitin ligases31-34. NIPA is responsible for the subcellular regulation of its 
substrate, cyclin B1, in interphase, thereby contributing to the timing of mitotic entry31. Cell cycle 
dependent inactivation of the SCFNIPA complex is governed by the inhibitory phosphorylation of NIPA in 
late G2 phase by the action of cyclinB1-CDK1 and ERK2 kinases
33,35, leading to the disruption of E3-
ligase activity. Although the molecular mechanism of protein degradation that controls cell 
proliferation is well known, many mechanistic questions still remain elusive36. 
Here we show that NIPA is associated with the NPC by a direct interaction with the nucleoporin TPR. 
We identify the zinc-finger motif within NIPA to be responsible for the binding to TPR and moreover 
that disruption of this domain leads to the dissociation of NIPA from the NPC. We therefore propose 
an intriguing mechanism for the regulation of cyclin B1 nuclear abundance by recruiting ubiquitin 
ligase mediated degradation to the gates of the inner nuclear envelope. 
Materials and methods 
Plasmids, antibodies and immunological procedures. 
Details of the construction of various plasmids are available from the authors upon request. The 
plasmids for FLAG-NIPA-pcDNA3.1 wild type, zinc-finger mutant and nuclear localization signal (NLS) 
mutant were kindly provided by C. v Klitzing. GFP-NIPA wild type and GFP-NIPA zinc-finger mutant 
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were subcloned into pEGFP-C3 vector (Clontech). cDNA of NIPA was cloned into pcDNA-N-SF-TAP 
(vector was kindly provided by M. Ueffing37). pcDNA3.1-FbxO9, pcDNA3.1-Fbw2 and pcDNA3.1-Fbw11 
plasmids were a generous gift provided by F. Bassermann. Vector encoding human pEGFP-TPR was 
obtained from Addgene (Addgene plasmid 35024, P. Frosst18). Plasmid transfections were performed 
using TurboFect (Thermo Fisher) or Lipofectamin 2000 (Invitrogen) according to the manufacturer’s 
instructions. Antibodies used in this study included mouse monoclonal antibodies from Sigma-Aldrich 
(-actin (AC-15); FLAG-M2), Santa Cruz (NIPA (B-10, sc-365058)), ActiveMotif (α-tubulin (5-B-1-2)) and 
Abcam (NUP153 (QE5)); rabbit polyclonal and monoclonal antibodies from Sigma-Aldrich (ZC3HC1 
(HPA024023)), Abcam (p-NIPA (ab63557)) and Cell Signaling (NUP98 (C37G10)); and goat polyclonal 
antibodies from Santa Cruz (TPR (C-20); Lamin B (M-20)). All secondary antibodies used for 
immunofluorescence were from Invitrogen (Anti-Rabbit IgG, Alexa Fluor 488; Anti-Rabbit IgG, Alexa 
Fluor 594; Anti-Mouse IgG, Alexa Fluor 594; Anti-Mouse IgG, Alexa Fluor 488 and Anti-Goat IgG, 
Alexa Fluor 594). Extract preparation, immunoprecipitation and immunoblotting were performed as 
previously described31,34,35. Nuclear fractionation was performed using Dounce homogenizer as 
previously described38. 
Immunofluorescence staining and structured illumination microscopy.  
Cells were grown to 80% confluence on high precision microscope cover glasses (Roth), fixed with 
formaldehyde and permeablized with 0.5% Triton X-100 in PBS containing 0.02% Tween-20 (PBST). 
After blocking (2% BSA in PBST) for 1 h), staining was carried out by incubation with the primary 
antibodies (1 h at 1:200-1:500 dilutions in 2% BSA). Slides were then incubated with secondary 
antibodies (typically 1:400 in 2% BSA), postfixed with formaldehyde and nuclei were counterstained 
with DAPI (1 g/ml in PBST). Finally, cover glasses were mounted onto microscope slides (SuperFrost 
PLUS) in VECTASHIELD (Vector Laboratories). Confocal images were taken with an UltraVIEW VoX 
spinning disc microscope (PerkinElmer) assembled to an Axio Observer D1 inverted stand (Zeiss) and 
using a 63x/1.4 NA Plan-Apochromat oil immersion objective. 
3D-SIM was performed on a DeltaVision OMX V3 (Applied Precision) system equipped with a 
100x/1.40 NA PlanApo oil immersion objective (Olympus), Cascade II: 512 EMCCD cameras 
(Photometrics) and 405, 488 and 593 nm diode lasers as previously described39,40. 
Live cell microscopy, fluorescence loss in photobleaching and quantitative fluorescence recovery 
after photobleaching analysis 
Live cell imaging, fluorescence loss in photobleaching (FLIP) and fluorescence recovery after 
photobleaching (FRAP) experiments were performed on an UltraVIEW VoX spinning disc microscope 
(PerkinElmer) as described before41. For acquisition the 488 nm laser line was set to 8-20% 
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transmission and the exposure time was set to 200 ms. For bleaching the 488 nm laser line was set to 
100% transmission. 
In FLIP experiments a rectangular region in the nucleus of 5x5 µm was repeatedly bleached. 2-4 cells 
were bleached in parallel. After 2 initial prebleach frames with a time interval of 5 s, 21 bleach cycles 
were performed. Each bleach cycle consisted of a bleaching event of 500 ms followed by 2 
postbleach frames with a time interval of 5 s. To evaluate the data, the mean intensity of the 
peripheral region, was determined over time. The outer border was determined using the “Auto 
threshold” function and the inner border was determined by eroding the selected region 4 times. 
Afterwards, the background intensity was subtracted from these results and the intensities relative to 
the first postbleach frame were determined. The measurements were performed in Fiji42 followed by 
calculations in Excel. 
In FRAP experiments a rectangular bleach region, covering approximately half of the nucleus, was 
chosen. Like in the FLIP experiments 2-4 cells were bleached in parallel. In order to capture fast 
kinetics (Fig. 1D) 10 prebleach frames with a time interval of 1 s were recorded, followed by a bleach 
event of 700-900 ms and 60 frames with a time interval of 1 s and further 4 frames with a time 
interval of 1 min. For the detection of slow dynamic processes (Fig. 4D) z-stacks of 3 µm with a step 
size of 1 µm were recorded every 2 min. After 2-12 prebleach frames, the points were subsequently 
bleached manually, with a 10-15 s delay between bleaching and the first postbleach frame.  
In long term imaging experiments a z-stack of 10.5 µm with a step size of 1.5 µm was recorded every 
10 min for about 30 h. To avoid photodamage of the cells the ATOF of the laser was set to low 
transmission values of 8%.  
siRNA 
siRNAs were purchased from Eurofins and were used to transfect subconfluent HeLa or U2OS cells 
using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. NIPA siRNA 
corresponded to sense CAGAUUGAAUCGUCCAUGAd(TT)31 and TPR siRNA to sense 
GUAAUGAGCAGCAAGCCAGd(TT)43. A firefly luciferase siRNA served as a control.  
Purification of NIPA interactors  
HEK293T cells were transfected with an NIPA-tandem-Strep-single-FLAG-tagged (NIPA-SF-TAP) 
construct as described previously44. Purification was performed as described45. The final eluate was 
boiled in LDS buffer, and then separated on a NuPAGENovex 4‐12% Bis‐Tris Mini Gel. Gel lanes 
containing separated immunocomplexes were cut into slices and in-gel trypsin digestion was 
performed following standard protocols.  
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LC-MS/MS and data analysis 
Dried samples were dissolved in 0.1% formic acid (FA) prior to LC-MS/MS analysis. Nanoflow LC-
MS/MS was performed by coupling a nanoLC-Ultra (Eksigent, CA) to a LTQ Orbitrap XL mass 
spectrometer (Thermo Fisher Scientific, GER), using a 20mm x 75 um ReproSil-Pur C18 (Dr. Maisch, 
GER) precolumn followed by a 400 mm x 50 um ReproSil-Pur C18 (Dr. Maisch, GER) analytical column. 
Peptide mixtures were analyzed during a 110 min gradient from 0 to 40% B (0.1% FA in AcN). The 
eluent was sprayed via emitter tips (New Objective) butt-connected to the analytical column. 
The mass spectrometer was operated in data dependent mode, automatically switching between MS 
and MS/MS. Full scan spectra (from m/z 350 – 1200) were acquired in the Orbitrap with a resolution 
of 60 000 (at m/z 400) after accumulation to target value of 1E6. The 15 most intense ions at a 
threshold above 5000 ion counts were selected for collision‐induced fragmentation in the linear ion 
trap (LTQ) at a normalized collision energy of 35%. Peak lists were extracted from MS data files using 
Mascot Distiller v2.2.1 (Matrix Science, UK) and subsequently searched against the Human IPI 
database version v3.68 using Carbamidomethyl cysteine as a fixed modification and Oxidation (M), 
Phospho (ST) as variable modifications. Trypsin was specified as the proteolytic enzyme and up to two 
missed cleavages were allowed. The mass tolerance of the precursor ion was set to 5ppm and for 
fragmentations to 0.6 Da. Data interpretation was performed with Scaffold2, v3.3.0. Proteins were 
filtered using a minimal protein identification probability of 99% and minimal peptide identification 
probability of 95%.  
Cell culture 
HeLa, U2OS, primary NIPA-deficient MEFs46 and HEK293T cells were cultivated in DMEM 
supplemented with 10% FCS and penicillin/streptomycin or gentamycin in a humidified atmosphere of 
5% CO2 at 37C.  
Results 
We previously characterized NIPA as an F-box containing protein, which is localized exclusively in the 
nucleus, by using affinity-purified polyclonal murine NIPA antiserum31. This antibody yielded a bright 
immunofluorescent signal, staining the whole nuclear interior. Recently, more specific antibodies, 
raised against human NIPA protein, have become commercially available (Sigma-Aldrich HPA024023 
and Santa Cruz sc-365058) showing explicit staining of the nuclear periphery. As shown in Figure 1A 
(and Supplementary Figure 1) these antibodies detect NIPA at the nuclear periphery. To gain more 
insights into the precise localization of NIPA at the nuclear periphery, we performed super-resolution 
imaging, with 3D-structured illumination microscopy (3D-SIM)40. With this imaging technique, we 
analyzed the localization in respect to the nucleoporin NUP153 and a structural component of the 
Kulinski, Schneider et al. 
126 
nuclear lamina, LaminB47,48. NIPA was found at the nuclear periphery in a region still stained by DAPI, 
but rather below NUP153 and Lamin B, suggesting not the nuclear membrane localization but rather a 
nuclear basket association (Fig. 1B).  
Although immunostaining can reveal protein location in the steady state, it is not sufficient to provide 
information about the dynamic localization49. To obtain a more detailed picture of the subcellular 
localization and dynamics of NIPA, we generated a GFP-NIPAWT fusion protein and examined the 
localization by a combination of fluorescence loss in photobleaching (FLIP) and fluorescence recovery 
after photobleaching (FRAP) (Fig. 1 C, D). 
In FLIP experiments, the molecules in a region within the cell are repeatedly photobleached by an 
intense laser pulse. A decrease in intensity outside the bleached region allows for assessing the 
mobility of a protein between intracellular compartments and for measuring the kinetics of 
recruitment to the bleached region from various cellular areas50. When massively overexpressed, GFP-
NIPAWT shows a diffuse nuclear localization in contrast to the endogenous protein, which is localized at 
the nuclear envelope (compare Fig. 1A and 1C middle panel).  However, when GFP-NIPAWT levels were 
low, a profound localization to the nuclear periphery was observed (Fig. 1C, lower panel). The 
repeated bleaching in the small nuclear region resulted in almost complete loss of fluorescence inside 
the nucleus, leaving a strong signal in the peripheral compartment. These results show that the NIPA 
molecules at the nuclear envelope do not diffuse through the bleached area in the observed time 
frame of two minutes, indicating that NIPA is bound stably at the nuclear envelope. In contrast to this, 
the diffuse nuclear fraction of the protein when artificially high overexpressed is very mobile, 
comparable to free diffusing GFP. Together these results indicate that NIPA is stably bound to the 
nuclear periphery. In a complementary approach we used FRAP to further analyze the dynamics of 
GFP-NIPAWT. In FRAP experiments, the recovery of intensity in a bleached region is observed over 
time. The faster the recovery, the more mobile the protein is. Like in the FLIP experiment, we could 
observe a very fast recovery of the nuclear fraction of GFP-NIPAWT in high expressing cells, comparable 
to free GFP in the nucleus (Fig. 1D). However, in low expressing cells, we did not see a recovery at the 
nuclear periphery even after five minutes. Full recovery takes up to one hour (Fig. 4D), confirming the 
strong association of GFP-NIPA with the nuclear envelope.  
Next, we wanted to determine if NIPA localization at the nuclear envelope changes during cell cycle 
progression. Live imaging of cells expressing low GFP-NIPAWT was performed while the cell entered 
and accomplished mitosis (Fig. 1E). The nuclear envelope is disassembled during mitosis in higher 
eukaryotes and integral membrane proteins, such as lamin receptors or nuclear pore proteins, are 
dispersed throughout the endoplasmic reticulum51,52. NIPA shows a strong membrane co-localization 
until the cell reaches mitosis, where the envelope localization disappeared, most probably around 
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nuclear envelope breakdown (NEB) (Fig. 1E). At that time the cell entered prometaphase and NIPA 
became soluble in the cytoplasm. Membrane localization reappeared around nuclear envelope 
assembly, analogous to other NPC proteins53. All these data suggest, that NIPA is strongly anchored to 
the nuclear envelope. 
 
Figure 1. NIPA is localized and stably bound to the nuclear envelope. All experiments were performed in HeLa cells. (A) 
Representative confocal image of a cell stained with antibodies against endogenous NIPA (green) and Tubulin (red). Nuclei 
were counterstained with DAPI (blue). (B) 3D-SIM super-resolution images of cells stained with antibodies against 
endogenous NIPA (green) and NUP153 or Lamin B (red). Nuclei were counterstained with DAPI (blue). Eight-fold 
magnifications of the outlined regions are shown. (C) Representative FLIP experiment of GFP and GFP-NIPA
WT
 in high and low 
expressing cells. A rectangular region of 5x5 µm indicated by the dashed line was repeatedly bleached. (D) Representative 
FRAP experiment of GFP and GFP-NIPA in high and low expressing cells. A rectangular region covering half of the nucleus 
indicated by the dashed line was bleached once and the recovery in this area was observed over time. (E) Life cell imaging of 
a representative GFP-NIPA transfected HeLa cell undergoing mitotic division. Images in A, C-E were acquired at a confocal 
spinning disc microscope and optical mid sections are shown in all images. Scale bars: 5 µm and 1 µm (magnifications). 
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In order to determine biologically relevant interactions of NIPA, we combined tandem affinity 
purification (TAP) with mass spectrometric analyses. Table 1 shows a selected list of targets found in 
our screen.  
 
Table 1. Identification of NIPA interactors by mass spectrometry. HEK293T cells were transfected with a NIPA-tandem-
Strep-single FLAG-tagged (NIPA-SF-TAP) construct and after purification with Streptactin and FLAG resin, samples were 
separated on an SDS-PAGE Gelelectrophoresis. Gel lanes were cut into slices and in-gel trypsin digestion was performed 
followed by LC-MS/MS analysis. Table 1 represents proteins with the highest sequence coverage.  
As a third score we identified S-phase kinase-associated protein 1 (SKP1), which together with NIPA 
builds a functional SCF ligase. Interestingly, as a top scoring protein we also identified the nucleoporin 
TPR with the highest sequence coverage. TPR is a structural element of the NPC constituting the 
nuclear basket. Thus it´s high affinity to NIPA found in the proteomic analysis strongly suggests a co-
localization in this nuclear compartment. To further investigate the interaction between NIPA and 
TPR, we performed immunoprecipitation assays (Fig. 2). As a control we overexpressed different F-box 
proteins (FBPs) to eliminate the possibility that TPR was a “sticky” protein that bound non-specifically 
to other proteins in vitro. We transfected FLAG-tagged NIPA, FBXO9, FBW2 and FBW11 into HEK293T 
cells and performed precipitations using anti-FLAG beads. NIPA was the only F-box protein (among 
four tested) that co-immunoprecipitated with endogenous TPR (Fig. 2A). Additionally, after nuclear 
fractionation, FLAG-tagged NIPA was efficiently immunoprecipitating TPR from the nuclear extracts 
showing that the NIPA-TPR interaction takes place in the nucleus (Fig. 2B). Vice versa overexpressed 
TPR was able to co-immunoprecipitate endogenous NIPA (Fig. 2C) confirming a specific interaction 
between TPR and NIPA. Altogether, in agreement with the results of mass spectrometry, 
immunoprecipitation experiments proof that NIPA specifically binds to the nucleoporin TPR. 
NIPA was previously characterized as an F-box protein, containing an NLS domain for the nuclear 
localization as well as a zinc-finger-like domain in the N-terminus as a potential substrate interaction 
motif33 (Fig. 3A). Following the identification of TPR as an interaction partner of NIPA, we were 
interested to identify the exact TPR-binding region within NIPA. Therefore we generated FLAG-tagged 
NIPA constructs by introducing point mutations into the characteristic motifs and performed co-
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immunoprecipitations against endogenous TPR (Fig. 3B). HEK293T cells were transfected with FLAG-
tagged NIPA: wild type (WT); zinc-finger mutant (ΔZnF) and nuclear localization signal mutant (ΔNLS) 
along with an empty vector as a control and immunoprecipitation was performed using FLAG beads. 
Consistent with previous results, FLAG-NIPAWT binds efficiently to TPR (Fig. 3B). Interestingly, a 
mutation in the zinc-finger-like domain of NIPA resulted in complete abrogation of the binding to TPR, 
showing substrate interaction abilities of the zinc-finger domain 33 (Fig. 3B). 
Figure 2. NIPA protein interacts with TPR. (A) HEK293T cells were transfected with the indicated FLAG-tagged F-box proteins 
(FBPs) and then immunoprecipitated (IP) with anti-FLAG beads. Immunocomplexes were probed with antibodies against 
indicated proteins. (B) FLAG-tagged NIPA was overexpressed in HEK293T cells and cell fractionation was performed to obtain 
nuclear fractions (NF). IP was performed using anti-FLAG beads, blotted and probed with anti-TPR antibody. Empty vector 
(EV) was transfected as a control. (C) TPR was overexpressed (OVE) in HEK293T cells and together with endogenous (END) 
protein immunoprecipitated with anti-TPR antibody. Co-immunoprecipitation with NIPA was detected in Western blot using 
anti-NIPA antibody. WCE – whole cell extracts.  
In order to determine whether binding to TPR via the zinc-finger domain is required for NIPA to 
localize to the nuclear envelope we performed FLIP experiments using GFP-fusion proteins (Fig. 3C, 
Fig. S2). Cells expressing GFP-NIPAWT, GFP-NIPAΔZnF or GFP-NIPAΔF-box were repeatedly photobleached 
in a central nuclear region, and images were taken in between. GFP-NIPAWT was localized at the 
nuclear membrane after photobleaching (Fig. 3C upper panel). In contrast, photobleaching of the GFP-
NIPAΔZnF protein resulted in the loss of fluorescence in the whole nucleus including the nuclear 
envelope (Fig. 3C middle panel). This indicates that the zinc-finger domain is necessary for anchoring 
NIPA to the NPC. Next we photobleached cells expressing the GFP-NIPAΔF-box mutant, to determine if a 
functional SCF-complex is required for anchoring NIPA to the NPC. Bleaching experiments 
demonstrated no requirement of a functional SCF complex, because the F-box mutant of NIPA, which 
is unable to bind to the SKP1 subunit of the SCF, was still present at the nuclear envelope after 
photobleaching (Fig. 3C, lower panel).  
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Figure 3. Zinc-finger motif in NIPA is responsible for the binding to TPR at the NPC. (A) Domain structure of NIPA depicting 
zinc-finger motif (ZnF), F-box motif and nuclear localization signal (NLS). (B) HEK293T cells were transfected with FLAG-tagged 
NIPA constructs: NIPA wild type (WT), NIPA zinc-finger mutant (ZnF) and NIPA nuclear localization signal mutant (NLS) and 
empty vector (EV) as a control. Whole-cell extracts (WCE) were immunoprecipitated with anti-FLAG beads and the indicated 









mutant in HeLa cells performed at a spinning disc confocal microscope. A rectangular region indicated by the 





mutant. The fixed cells were stained with antibodies against endogenous TPR 
(red) and the GFP signal was enhanced using the GFP-booster (ChromoTek, green). Nuclei were counterstained with DAPI 
(blue).   
Finally we also applied super-resolution microscopy to study the importance of the zinc-finger domain 
for NIPA localization at the NPC (Fig. 3D). We investigated GFP-NIPAWT and GFP-NIPAΔZnF mutant 
protein in HeLa cells. In agreement with previous findings, the wild type protein was located at the 
NPC, co-localizing with TPR (Fig. 3D left panel), whereas the zinc-finger mutation resulted in 
subnuclear mislocalization of the protein from the NPC (Fig. 3D right panel). Taken together, these 
data strongly suggest that the zinc-finger domain encoded in the N-terminus of NIPA is responsible for 
the interaction with the nucleoporin TPR and that this interaction localizes NIPA to the nuclear pore 
complexes. 
The role of TPR as an architectural element of the NPC was reported previously11. However, in another 
report the scaffolding abilities of TPR have been controversially discussed12.  Therefore, we aimed to 
assess whether TPR is required for anchoring NIPA to the NPC. In order to determine the ability of TPR 
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to tether NIPA to the NPC, we suppressed TPR synthesis by synthetic siRNA in HeLa cells (Fig. 4A). As 
shown by western blot analysis, the level of TPR was specifically reduced after 72 h of treatment with 
siRNA with immunofluorescence. Interestingly, down-regulation of TPR at the same time leads to 
degradation of NIPA, whereas transient down-regulation of NIPA by siRNA treatment had no clear 
effect on TPR expression (Fig. 4A). These data indicate that TPR is required for the stability of NIPA.  
 
Figure 4. TPR constitutes the essential anchoring element for NIPA localization at the NPC. (A) HeLa cells were transfected 
with siRNA and subjected to immunoblotting with the indicated antibodies after 72 h. (B) U2OS cells were treated with 
siRNAs (NIPA and TPR) for 48 h and stained with antibodies against endogenous NIPA (red) or TPR (green). Nuclei were 
counterstained with DAPI (blue). Scale bar: 5 m. (C) Different mouse embryonic fibroblasts (MEFs) cell lines derived from 
NIPA deficient (-/-) or NIPA wild type (+/+) mice were subjected to immunoblot analyses and probed with indicated 
antibodies. (D) Representative FRAP experiment in GFP-NIPA
WT
 or GFP-TPR expressing HeLa cells. A rectangular region 
covering half of the nucleus indicated by the dashed line was bleached once and the recovery in this area was observed over 
time with spinning disk confocal microscopy. Scale bar: 5 m.  
We next analyzed down-regulation of NIPA and TPR by siRNA for their nuclear envelope localization. 
As seen in Figure 4B, cells treated with TPR siRNA showed partial depletion of TPR which lead to 
severe down-regulation of NIPA from the whole nuclear compartment. In contrast, knockdown of 
NIPA with siRNA did not alter the localization of the TPR staining at the nuclear periphery (Fig. 4B). 
Furthermore, results from different immortalized MEF cell lines, obtained from NIPA wild type and 
knockout mice, showed similar TPR levels in cells lacking NIPA expression when compared to the wild 
type (Fig. 4C). Hence, TPR downregulation alters the distribution of NIPA in the nucleus and is 
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therefore crucial for its proper nuclear localization and stability, whereas NIPA depletion has no visible 
effect on TPR expression or localization. 
To further investigate the anchoring abilities of TPR towards NIPA, we compared protein mobility 
using the method FRAP. We employed FRAP analysis to test the nuclear kinetics of the GFP-tagged 
NIPA and TPR by bleaching the fluorescence in half of the nucleus with a high-power laser and tracking 
the rate of nuclear membrane recovery over two hours. The recovery of GFP-TPR at the nuclear 
envelope was slower than that of GFP-NIPA, denoting slower TPR protein dynamics, thereby 
suggesting a stronger association with the nuclear envelope in comparison to NIPA (Fig. 4D). In 
summary, these results strongly indicate that TPR acts as a scaffold protein targeting NIPA to its stable 
binding site at the NPC.  
Discussion 
Post-translational modifications are fundamental controlling mechanisms responsible for intracellular 
signaling pathways. Ubiquitin-mediated proteasomal degradation of proteins plays an important role 
among them, since it was shown to be crucial for the control of cellular events like cell-cycle 
progression54. Due to their ability of substrate recognition, F-box proteins play the main role in 
ubiquitin-mediated proteolysis. We previously characterized a new SCF-E3 ligase SCFNIPA, in which the 
nuclear F-box protein NIPA is responsible for targeting cyclin B1 for degradation in interphase, thereby 
contributing to the timing of mitotic entry31.  
In this study, we have analyzed the localization of NIPA in more detail and were able to show that 
NIPA is not only part of the nuclear envelope but is mainly localized to the nucleoplasmic face of the 
NPC. We found that the localization of NIPA to the NPC is mediated by its binding to the nucleoporin 
TPR at the nuclear basket. A previous study pointed out the controversial role of TPR as an 
architectural element of the NPC12. Although it was revealed that TPR is tethered to the NPC by the 
interaction with NUP153, the question whether TPR itself acts as a scaffold onto which other NPC 
components need to be assembled still remained elusive. Here we show that TPR is the anchoring 
protein for NIPA and that this strong interaction is essential for the proper localization of NIPA to the 
NPC. Silencing of TPR by synthetic siRNA resulted in destabilization of NIPA and it subsequent 
degradation, confirming the role of TPR as a scaffolding protein.  We also identified the zinc-finger 
motif in NIPA as being responsible for the binding to TPR and showed that disruption of this domain 
leads to mislocalization of NIPA from the nuclear pore. In contrast, mutation of the F-box domain did 
not affect the localization, indicating that a functional SCF complex is not necessary for the association 
with the NPC. These findings implicate that NIPA is a nuclear pore associated protein and suggest a 
functional relevance for its localization.  
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Previous reports by others have shown that TPR is both a substrate and a scaffold for activated ERKs22. 
It was reported that phosphorylation of TPR by ERK stabilizes their interaction what in consequence 
positions ERK2 for the phosphorylation of further potential substrates at the NPC. In addition, ERK-TPR 
interaction regulates the translocation of activated ERK222. Moreover, Kosako et al. demonstrated that 
ERK is a physiological nucleoporin kinase and suggested a role for TPR in ERK-mediated 
phosphorylation at the nuclear pore55. Interestingly, our recent study revealed NIPA as an exclusive 
substrate of ERK2 and that this phosphorylation leads to disruption of the SCFNIPA activity35. Hence, we 
hypothesize the existence of a scaffold located at the NPC, constituted by the filaments of TPR, which 
allows for positioning of both, the kinase and the substrate, in close proximity. In this model, ERK2 
may require a platform constituted by TPR to efficiently phosphorylate NIPA at the NPC. We observed 
lack of a phosphorylation in the SDS-PAGE when NIPA was overexpressed in cells with mutated zinc-
finger motif, supporting our assumption (data not shown). Zinc-finger mutation abrogates the binding 
to TPR, leading to mislocalization of the protein to the nuclear interior (Fig. 3). As a result, it is 
conceivable that ERK2 cannot phosphorylate NIPA due to the loss of its anchoring site at the NPC.  
Spatial control of the proteolysis is emerging as an important regulator of mitotic transitions56. 
Anaphase promoting complex/cyclosome (APC/C) could serve as an example of controlled protein 
degradation in space and time. It has been proposed that the Cdc20-APC/C complex, associated with 
the mitotic spindle, targets cyclin B for degradation in the early phase of mitotic exit therefore 
activating the Cdh1-APC/C complex further to target cyclin B for destruction throughout the cell, 
leading to mitotic exit57. Other regulatory mechanisms exist which rely on the compartmentalization 
of the protein turnover. For instance, ER-associated protein degradation (ERAD) is an ubiquitin-
proteasome based system responsible for the degradation of membrane and luminal proteins of the 
endoplasmic reticulum, and E3 ligases participating in this process are localized to the ER/nuclear 
envelope58,59. Also SUMO proteases were recently connected with the filaments of the NPC28,29,60. All 
these evidence argue for the growing importance of the spatial control of protein degradation, 
restricting the recognition of substrates and functional proteolysis to specific cellular compartments. 
Although at this moment, we can only speculate about the exact function that NIPA may have at the 
NPC, our findings, which revealed NIPA localization at the nuclear pore, are especially relevant with 
respect to the ubiquitin proteasome system. This study provides additional evidence on the specific 
localization of an E3 ligase, which could predestinate its function according to the substrate of NIPA – 
cyclin B1. Therefore we propose a model, complementing our previous observations31, in which NIPA 
guards the genome integrity by controlling cyclin B1 abundance in space and time (outlined in Figure 
5). Consistently, NIPA localizes to the nucleoplasmic site of the NPC by the interaction with TPR and is 
able to transfer ubiquitin directly on cyclin B1 when it crosses the nuclear barrier prematurely in 
interphase. Such a model suggests the formation of a “cyclin trap” directly at the gate, targeting cyclin 
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B1 for degradation just upon entry to the nucleus (Fig. 5A). At the G2/M phase of the cell cycle, NIPA is 
phosphorylated, what leads to dissociation of the SCFNIPA, allowing for accumulation of cyclin B1 and 
subsequent mitotic entry (Fig. 5B). Thus, according to our model, the NPC localization of NIPA could be 
essential for the spatial control of cyclin B1.  
 
Figure 5. Theoretical model of SCF
NIPA
 activity in the regard to its nuclear localization. The model postulates that the SCF
NIPA
 
complex is a gate guardian of the genome integrity by promoting degradation of cyclin B1 during interphase. (A) Cyclin B1 
enters the nucleus through the NPC (1), is directly ubiquitinated (2) and headed for the proteasomal degradation (3). (B) In 
the G2/M phase NIPA is phospohrylated (2), leading to the dissociation of the SCF
NIPA
 complex and its subsequent 
inactivation. Cyclin B1 can accumulate in the nucleus (3) triggering the G2 – M transition.  
Recently, Niepel et al. reported that Mlp1 and Mlp2, the yeast homologues of TPR, are major NPC 
basket components and showed that these proteins constitute a dynamic interactome, together with 
Esc1p and the proteasome61. This finding, which connects the proteasome to the vicinity of the 
nuclear pore, is a fascinating endorsement of our model suggesting that the whole protein 
degradation machinery might be organized at the same, specialized subcellular compartment – the 
nuclear pore complex. In this regard, TPR could function as a scaffold for NIPA, its regulatory kinase 
ERK2 as well as the proteasome within this model: upon translocation of cyclin B1 to the nucleus, NIPA 
directly transfers ubiquitin on the substrate, targeting it for immediate proteasomal degradation in 
situ and ERK2 directly controls NIPA during the cell cycle phases. Thus, our model provides an 
explanation for a tight and highly efficient guardian against the premature mitotic entry, maintaining 
genome integrity. 
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In summary, we have further characterized the previously identified F-box-containing protein NIPA as 
a novel nuclear pore associated protein and proposed that the specific localization of NIPA to the NPC 
may have a potential implication in the spatial control of cyclin B1 during mammalian cell cycle.  
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Supplementary Figure 1. Nuclear localization of NIPA detected with antibodies. The experiment was performed in HeLa 
cells. (A) Representative confocal image of cells stained with antibodies from Santa Cruz and Sigma-Aldrich against 
endogenous NIPA (red). Nuclei were counterstained with DAPI (blue). Images were acquired at a confocal spinning disc 




Supplementary Figure 2. Quantification of FLIP experiments shown in Figure 3C. Background corrected intensities of the 
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Although Dnmt1 has been studied for over 25 years (Bestor et al., 1988), the detailed regulation of 
maintenance DNA methylation still remains to be elucidated. Especially the cell cycle dependency of 
the regulatory interactions increases the complexity considerably. In order to gain new insights into 
the regulation of DNA maintenance methylation, we set out to dissect the cell cycle-dependent 
dynamics of Dnmt1. Our approach of combining FRAP with kinetic modeling enabled us to get 
quantitative insights into the binding processes. Furthermore, FRAP and related methods enabled us 
to analyze the dynamics of the factors Uhrf1, Uhrf2 and the histone variant H2A.Z. Emphasizing the 
methodological aspect of this work, we also developed new strategies to label DNA sequences in living 
cells, characterized nanoparticles as vectors for nucleic acids and detected new interactions of the cell 
cycle regulator NIPA.  
3.1 Spatio-temporal dynamics of epigenetic factors 
3.1.1 Cell cycle-dependent localization and kinetics of Dnmt1 
In order to dissect the cell cycle-dependent regulation of Dnmt1, we obtained detailed temporal and 
spatial information using FRAP in combination with kinetic modeling as well as 3D-SIM super-
resolution microscopy (Schneider et al., 2013). By analyzing GFP-Dnmt1 mutants, we showed that 
both the PBD- and the TS domain-mediated interactions are necessary and sufficient for the 
localization and the dynamics of Dnmt1 in S phase. In early S phase, binding of the PBD to PCNA 
predominates. In late S phase, we observe a shift towards the TS domain-mediated binding to 
constitutive heterochromatin (Figure 10). Based on our customized kinetic model that will be 
discussed in 3.2.2, we estimated the mean residence time (Tres) describing the average binding time of 
the PBD and the TS domain to their targets. The Tres was about 10 s for the PBD and about 22 s for the 
TS domain. The short Tres indicate transient interactions, which are in the range of the binding 
behavior of many nuclear proteins (Phair and Misteli, 2000, Phair et al., 2004b). Transient interactions 
facilitate the fast reaction of nuclear processes to external and internal signals. Based on our 
measurements, we propose a two-loading-platform model, in which PCNA and constitutive 
heterochromatin function as relatively immobile platforms during S phase. Furthermore, the 
interaction of the TS domain with constitutive heterochromatin is stronger than the interaction of the 
PBD with PCNA. If the specific heterochromatic marks, the TS domain binds to, are in close proximity 
to replication sites, Dnmt1 binding is shifted towards heterochromatin, a situation mainly 
encountered in late S phase and presumably in G2. In early S phase, these heterochromatic sites are 
sparse, not accessible or distant to replications sites and therefore the interaction with PCNA is 
dominating. Besides specific binding partners, modifications changing the conformation of Dnmt1 
might also be involved in the switch observed between early and late S phase. Several modifications of 
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Dnmt1 have been reported, such as acetylation, ubiquitination, phosphorylation, methylation and 
sumoylation (Du et al., 2010, Lee and Muller, 2009, Esteve et al., 2011), but their cell cycle-dependent 
appearance has to be further investigated. Furthermore, it is still uncertain, whether DNA methylation 
takes place on unpacked DNA or on DNA wrapped around nucleosomes. In vitro and in vivo studies 
give indications that Dnmts methylate mainly unpacked DNA, but to some extend Dnmt1 also seems 
to be capable of methylating specific sequences in nucleosomes (Felle et al., 2011a, Okuwaki and 
Verreault, 2004). The latter might function as a mechanism in G2 ensuring complete maintenance of 
methylation, if the process of maintenance methylation is much slower compared to replication and 
not enough Dnmt1 molecules can be recruited to unpacked DNA. Slow DNA methylation would result 
in hemimethylated sites in G2, which could explain the association of Dnmt1 with constitutive 
heterochromatin, which is CpG rich and replicates late, in this phase (Easwaran et al., 2004). 
 
Figure 10: Two-loading-platform model for Dnmt1 in S phase. Dnmt1 binds via the PBD to PCNA and via the TS domain to 
constitutive heterochromatin. In early S phase, the interaction with PCNA is dominating. In late S phase, the specific 
heterochromatic marks, the TS domain binds to are present in close proximity to replications sites. This leads to a stronger TS 
domain-mediated interaction that dominates the Dnmt1 dynamics in late S phase. 
Moreover, we identified another MC for Dnmt1 with a mean residence time of about 10 s present in 
all analyzed stages, including G1/late G2, when the Dnmt1 localization is diffusely distributed in the 
nucleus. This MC even persists in Dnmt1 mutants, where several regions are affected. In addition to 
mutations in the PBD and the TS domain, neither mutations in the ZnF (Frauer et al., 2011) nor N-
terminal truncations (unpublished data; bachelor’s thesis Anna Ulraum) resulted in faster kinetics in 
G1/late G2. Although we cannot exclude a specific, S phase independent interaction with for example 
chromatin, we attribute this fraction to anomalous diffusion in the nucleus. The common 
phenomenon of anomalous diffusion is further described and discussed in 3.2.3.  
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In addition to the temporal information, we analyzed the spatial distribution of Dnmt1 wild type 
(Dnmt1wt), a TS domain mutant and a PBD mutant in late S phase. Using super-resolution microscopy, 
we found that the Dnmt1wt localization is extended towards constitutive heterochromatin outside 
replication foci, if the PBD is mutated (GFP-Dnmt1Q162E). Interestingly, only a part of the chromocenter 
is covered. Based on pulse-chase experiments with the replication marker EdU, we hypothesize that 
the regions GFP-Dnmt1Q162E binds to consist of postreplicative heterochromatin containing the direct 
binding partner of the TS domain. The identity of this binding partner is still controversial and further 
discussed in 3.1.2. In addition, these results could point to a competition between the PBD mediated 
binding to PCNA and the TS domain mediated binding to postreplicative heterochromatin. This could 
explain the enrichment of Dnmt1 at constitutive heterochromatin in G2, when the replication of DNA 
is completed. PCNA would then be distributed diffusely in the nucleus and the TS domain could recruit 
a larger fraction of Dnmt1 molecules to constitutive heterochromatin.  
An interesting question is how the interactions of the PBD and the TS domain influence the catalytic 
activity of Dnmt1. We obtained first insights into this question by performing a trapping assay, in 
which Dnmt1 is covalently bound to 5-aza-dC (see 1.4.2) (Schermelleh et al., 2005). The results 
confirmed that the PBD is not essential, but enhances the probability for the covalent complex 
formation by approximately a factor of two (Schermelleh et al., 2007). If a central part of the TS 
domain is removed (GFP-Dnmt1ΔTS), trapping is still possible in vivo, but the kinetics are considerably 
decreased. This finding is in accordance with the fact that a radioactive assay revealed that the methyl 
group is still transferred to DNA in vitro (PhD thesis, Qin, 2011). However,  this mutant cannot rescue 
methylation in Dnmt1 knockout ESCs indicating that the functional TS domain is essential for the 
maintenance of methylation in vivo (PhD thesis, Qin, 2011). Taken together, GFP-Dnmt1ΔTS seems to 
be incapable of significantly restoring and maintaining methylation levels over several cell cycles in 
vivo due to its slow catalytic reaction kinetics.  
3.1.2 Dynamic regulation of Dnmt1 by cofactors 
Although we demonstrated that the TS domain is required for the correct localization and kinetics of 
Dnmt1 in S phase, the direct heterochromatic interaction partner of the TS domain remains unknown. 
Most likely the interaction partner is Uhrf1, however, it is still debated, whether it is the direct 
interaction partner of Dnmt1. It has been reported that in vitro Dnmt1 and Uhrf1 interact via the TS 
domain (Frauer and Leonhardt, 2011, Bashtrykov et al., 2013, Achour et al., 2008, Felle et al., 2011b), 
but controversial in vivo data about the localization of Uhrf1 during the cell cycle exist. If Uhrf1 
mediates the targeting of Dnmt1 to hemimethylated DNA via its SRA domain, one would expect Uhrf1 
at replication foci in early S phase. However, most publications describe only the association of Uhrf1 
with heterochromatin, and they often do not mention, whether this association takes place 
throughout the cell cycle or only in a specific phase (Rothbart et al., 2013, Nishiyama et al., 2013). In 
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late S phase, Uhrf1 associates with PCNA or other replication markers, when constitutive 
heterochromatin is replicated, but it is unclear, if Uhrf1 associates with also PCNA in early S phase and 
if Uhrf1 is diffuse or associated with constitutive heterochromatin in G1 and G2. In some cases, Uhrf1 
colocalization with PCNA in early S phase has been described using an anti-Uhrf1 antibody (Uemura et 
al., 2000) or a GFP fusion protein (Bostick et al., 2007). We observed that GFP-Uhrf1 and Uhrf1-GFP 
associate with chromocenters throughout the cell cycle (unpublished data; master’s thesis Veronica 
Solis) and similar results have been published using antibodies (Citterio et al., 2004, Papait et al., 
2007). In some publications that claim colocalization of Uhrf1 with PCNA, the early S phase stage is not 
shown (Sharif et al., 2007). Therefore, it is still not clear, whether Uhrf1 targets Dnmt1 to 
hemimethylated sites in early S phase. Trapping experiments that covalently bind Dnmt1 to 5-aza-dC 
revealed that Dnmt1 is covalently bound to DNA in early S phase, strongly indicating the presence of 
methylated sites in early replicating euchromatic DNA (Schermelleh et al., 2007, Schneider et al., 
2013). If Dnmt1 binds via the TS domain to Uhrf1 at hemimethylated sites in early S phase, we would 
expect different kinetics and localization of GFP-Dnmt1ΔTS compared to GFP-Dnmt1wt in early S phase. 
Indeed, we observe a reduced association of GFP-Dnmt1ΔTS with replications sites in early S phase and 
a change in the kinetics compared to GFP-Dnmt1wt, but we cannot resolve a distinct TS domain 
mediated MC in early S phase with our model. Based on our results, we cannot definitely answer, 
whether the TS mediated interaction of Dnmt1 with constitutive heterochromatin is directly 
dependent on Uhrf1. Uhrf1 knockout studies are only of limited informative value, because the low 
methylation levels in Uhrf1 knockout cells (Sharif et al., 2007) could by itself already explain the almost 
diffuse localization of Dnmt1 in late S phase in these cells (Bostick et al., 2007).  
Uhrf1 cannot only bind to hemimethylated DNA, but also to H3K9me3 (Bostick et al., 2007, Rottach et 
al., 2010, Rothbart et al., 2012). The function of H3K9me3 binding is still unclear, but it might act as a 
double safety mechanism to ensure methylation at heterochromatin and to protect euchromatic 
regions from inappropriate methylation. We were able to demonstrate that binding of H3K9me3 
peptides further increases the specificity of Uhrf1 for hemimethylated DNA in vitro (Pichler et al., 
2011). Vice versa, the affinity for H3K9me3 is enhanced by binding of hemimethylated DNA. In the 
literature, contradictory data about the question, whether the TTD or the PHD mediates the binding to 
H3K9me3 are present (Rottach et al., 2010, Karagianni et al., 2008). In recent publications, there is 
more and more evidence that the PHD has a general affinity for H3 or a specific affinity for unmodified 
H3R2 and that the TTD harbors the specificity for H3K9me3 (Rothbart et al., 2013, Xie et al., 2012, 
Cheng et al., 2013, Rajakumara et al., 2011, Wang et al., 2011, Pichler et al., 2011). In conclusion, 
coordinated action of both domains seems to be required for H3K9me3 binding. Due to contradictory 
data, it is still unclear, whether the interaction of Uhrf1 with H3K9me3 is essential for DNA 
methylation or not. Both scenarios have been reported (Rothbart et al., 2012, Liu et al., 2013a). 
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Differential analysis of methylated late replicating heterochromatic and early replicating euchromatic 
DNA might give new insights into the necessity of Uhrf1 histone binding for maintenance methylation.  
Despite the similarity in the overall-domain structure between Uhrf1 and Uhrf2, Uhrf2 cannot restore 
the low methylation levels in Uhrf1 knockout ESCs (Pichler et al., 2011). Furthermore, we found that 
Uhrf2 alone has no preference for hemimethylated DNA, but binding of Uhrf2 to H3K9me3 modified 
peptides induces a preference. Similar to Uhrf1 the affinity of Uhrf2 for H3K9me3 is enhanced by 
binding to hemimethylated DNA. Until now, no data from an Uhrf2 knockout have been published that 
would give important information about its function. Nevertheless, we and other groups have 
demonstrated that Uhrf1 levels are high in ESCs and low in somatic cells (Hopfner et al., 2000, Fujimori 
et al., 1998), whereas Uhrf2 possesses an opposite expression pattern (Pichler et al., 2011). This 
opposite expression pattern has also been observed during embryoid body differentiation, hinting at 
different roles of Uhrf1 and Uhrf2 during differentiation and development. We hypothesized that 
Uhrf2 might have a tight control function in differentiated cells, whereas Uhrf1 is less stringent, 
allowing more plasticity in undifferentiated ESCs. Furthermore, it was shown that Uhrf2 binds strongly 
to 5hmC and that overexpression leads to increased 5hmC, 5fC and 5caC levels by Tet-mediated 
oxidation (Spruijt et al., 2013). These results could point to a role of Uhrf2 in DNA demethylation, 
supporting the hypothesis of Uhrf2 as a control protein in somatic cells possibly assisting in the 
removal of misplaced methylation marks. Further experiments have to be performed to analyze the 
distinct roles of Uhrf1 and Uhrf2 in DNA methylation and demethylation. 
Recently, a new publication proposes a way, how Uhrf1 could indirectly target Dnmt1 to 
hemimethylated DNA sites. The authors have shown that the RING-finger type E3 ligase Uhrf1 
ubiquitinates H3 on lysine 23 (H3K23ub) (Nishiyama et al., 2013). This new modification is bound by 
Dnmt1 via the TS domain (Nishiyama et al., 2013). The Uhrf1 RING mutant, which is defective in H3K23 
ubiquitination, fails to mediate the rescue of DNA methylation levels in Uhrf1 knockout cells and its 
overexpression leads to a diffuse Dnmt1 localization. As the H3K23ub modification seems to be 
replication-dependent, it is tempting to speculate that this modification occurs only on postreplicative 
chromatin and might be the link for S phase-dependent targeting of Dnmt1 to heterochromatin. These 
results are summarized in a stepwise loading model consisting of three steps (Figure 11). (1) Uhrf1 
binds to hemimethylated DNA via the SRA domain in close proximity to H3K9me3 recognized by the 
TTD and the PHD and ubiquitinates H3K23 via the RING domain. (2) Dnmt1 is enriched at replication 
sites by binding to PCNA. (3) Dnmt1 binds to H3K23ub via the TS domain as a requirement for 
methylation of the hemimethylated site. In addition, there might be still undetected modifications or 




Figure 11: Stepwise loading model at hemimethylated DNA. (1) Uhrf1 binds to hemimethylated DNA via the SRA domain 
and to H3K9me3 via the TTD and PHD, leading to ubiquitination of H3K23 by the RING domain. (2) Interaction with PCNA 
enriches Dnmt1 at replication foci. (3) Dnmt1 binds to H3K23ub via the TS domain, followed by methylation of the 
hemimethylated CpG site. Only domains mediating the illustrated interactions are depicted. Closed and open lollipops 
indicate methylated and non-methylated CpG sites, respectively. 
Another layer of complexity is added by the fact that the TS domain alone fused to GFP binds with 
very high affinity to constitutive heterochromatin throughout the cell cycle (Easwaran et al., 2004; 
diploma thesis Daniela Meilinger; master's thesis Veronica Solis). Only in early to mid S phase, the TS 
domain is less enriched at heterochromatin and a rather diffusely distributed fraction can be found in 
the nucleoplasm (data not shown, diploma thesis Daniela Meilinger). The potential of the TS domain 
to bind replication independent to constitutive heterochromatin has to be masked in the full length 
Dnmt1 protein, because we usually do not observe Dnmt1 association with heterochromatin in G1 or 
late G2 phase. This is in accordance with the structure of Dnmt1, in which the TS domain is inserted 
into the DNA-binding pocket of the catalytic domain (Takeshita et al., 2011). One hypothesis is that a 
conformation change upon binding to a specific signal like H3K23ub flips the TS domain out of the 
catalytic pocket, resulting in tight binding of Dnmt1 to its substrate, stabilizing the catalytic reaction of 
Dnmt1. The signal bound by the TS domain could be identical with the signal leading to the release of 
the TS domain from the catalytic pocket like H3K23ub or the TS domain could then bind another 
substrate, for instance, another histone modification like H3K9me3, methylated DNA or Uhrf1.  
Confocal imaging can be used to exclude potential interacting molecules, if they are not colocalizing 
with the TS domain. Therefore, it will be interesting to see the distribution of the new histone mark 
H3K23ub during the cell cycle.  
A histone modification could be involved in the release of Dnmt1 from heterochromatin in late G2. 
Phosphorylation of H3S10 in late G2 by the Aurora B kinase leads to the dissociation of HP1 from 
H3K9me3 at constitutive heterochromatin (Mateescu et al., 2004, Hirota et al., 2005) and could serve 
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as a mechanism to remove Uhrf1 or Dnmt1 from heterochromatic sites. The association of Uhrf1 with 
H3K9me3 is independent of H3S10 phosphorylation (Rothbart et al., 2012). However, Dnmt1 might 
directly bind to H3K9me3 and could be released upon H3S10 phosphorylation (Patricia Wolf, data not 
shown). This would explain why Dnmt1 is lost from constitutive heterochromatin in late G2 (Easwaran 
et al., 2004). Furthermore, there is evidence that knockdown of Dnmt1 leads to reduced H3S10 
phosphorylation (Monier et al., 2007), possibly caused by changes in the local chromatin environment 
due to local demethylation.  
DNA methylation is not only orchestrated by targeting Dnmt1 to the correct sites, but also by 
regulating its abundance and activity. Besides the already mentioned ubiquitination by Uhrf1 and 
deubiquitination by Usp7 (1.2.1), inhibition of Dnmt1 by non-coding RNAs has been recently 
demonstrated (Di Ruscio et al., 2013). Accordingly, long non-coding RNAs, produced during 
transcription, inhibit Dnmt1 activity at these loci, thereby keeping actively transcribed regions 
unmethylated. Furthermore, the potential of active DNA demethylation by Tet proteins has added a 
new layer of regulatory potential to the field of DNA methylation (Pastor et al., 2013). Besides the 
pathways illustrated in the introduction (see 1.2), dehydroxymethylation of 5hmC to 5C directly by 
Dnmt3a and Dnmt3b has been reported in vitro (Chen et al., 2012). If the direct conversion of 5hmC to 
5C by Dnmts occurred in vivo, this would open a large regulatory potential as Dnmt3a and Dnmt3b 
could immediately methylate the newly generated 5C sites back to 5mC. In cooperation with Tet 
proteins and Dnmt1 they would be able to regulate DNA methylation via numerous pathways in a very 
dynamic fashion. 
3.1.3 Connection between DNA methylation and histone variants 
DNA methylation might not only be connected to histone modifications, but also to histone variants. It 
has been reported that the incorporation of H2A.Z and DNA methylation are mutually exclusive in 
plants, indicating that H2A.Z protects DNA from methylation or vice versa (Zilberman et al., 2008). This 
mechanism seems to be conserved and has also been identified in mammals (Conerly et al., 2010). 
Moreover, inhibition of Dnmts by 5-aza-dC leads to incorporation of H2A.Z into chromatin and is 
essential for gene activation after 5-aza-dC treatment (Yang et al., 2012). The described results 
demonstrate the importance of histone variants as epigenetic regulators and hint at a connection with 
DNA methylation.  
One way how histone variants may influence epigenetics is via changing nucleosome stability. It was 
very interesting to see that a splice variant of H2A.Z is present in human cells with highest levels in 
brain tissue (Bonisch et al., 2012). In contrast to H2A.Z, the splice variant of the isoform H2A.Z.2, 
termed H2A.Z.2.2, can affect nucleosome stability. In FRAP experiments we could attribute around 
78% of the H2A.Z.2.2 molecules to a fast recovering fraction, whereas about 82% of the previously 
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characterized H2A.Z.2.1 molecules recovered slowly, pointing to an enhanced exchange of the splice 
variant in chromatin. Furthermore, we demonstrated that a specific sequence in the C-terminal part is 
necessary for the fast kinetic exchange of H2A.Z.2.2 by weakening the interaction with H3. Like H2A.Z, 
H2A.Z.2.2 interacts with the Tip60 and SRCAP chaperone complexes (Bonisch et al., 2012). This 
establishes an interesting link to Dnmt1, as Tip60 has been shown to regulate Dnmt1 levels by 
activating Uhrf1-dependent proteasomal degradation of Dnmt1 (Du et al., 2010). One could speculate 
that the incorporation of the active mark H2A.Z in chromatin constitutes a safety mechanism that 
degrades Dnmt1 at actively transcribed sites. Further experiments have to be performed in order to 
investigate this potential connection and the specific function of the splice variant H2A.Z.2.2. It will be 
interesting to analyze the functions of histone variants during development and disease, especially in 
connection to other epigenetic processes like DNA methylation. 
3.2 Visualizing the invisible 
For all complex nuclear processes, it is of fundamental importance to understand them not only in 
vitro, but also in an in vivo situation. Advanced microscopy in combination with fluorescent proteins 
like GFP offers a variety of techniques that enables us to gain deep insights into epigenetic regulation 
in vivo. New or improved ways of delivery, labeling or quantification of results can further help us to 
address biological questions about nuclear dynamics.  
A great advantage of the photobleaching method FLIP (see 1.4.2) is the exposure of regions, where the 
proteins strongly binds to, if the binding sites have been masked by a large diffuse mobile fraction. For 
instance, by bleaching the mobile fraction, we revealed that the protein NIPA binds strongly to the 
nuclear periphery. Before, the localization of the protein has only been described as nuclear 
(Bassermann et al., 2005). NIPA is a mammalian ubiquitin E3 ligase that ubiquitinates cyclinB1 
(Bassermann et al., 2005). At the G2/M transition, NIPA is inactivated by phosphorylation and cyclinB1 
accumulates, allowing mitotic entry. Our data demonstrate that GFP-NIPA needs several hours to 
recover in a FRAP experiment at the nuclear periphery in contrast to the diffuse fraction in the 
nucleoplasm that recovers in the range of seconds. A functional role of the nuclear fraction cannot be 
excluded, however, antibody staining showed that this fraction is rather small for the endogenous 
protein and might be an overexpression artifact of the exogenous construct. Detection of hidden 
patterns of protein localization can reveal colocalization with other proteins that has been masked 
before and give therefore new functional insights. In this context, the localization of NIPA at the 
nuclear envelope has led the attention to in vitro data indicating the nucleoporin translated promoter 
region (TPR) as an interaction partner. Using in vivo FRAP and FLIP experiments in combination with in 
vitro coimmunoprecipitation experiments, we demonstrated that the ZnF domain of NIPA is mediating 
the interaction to TPR. The extracellular signal-regulated kinase (ERK2) phosphorylates NIPA at the 
G2/M transition (Illert et al., 2012) and interestingly it has been reported that ERK2 is also able to 
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phosphorylate the protein TPR, leading to a stabilization of their interaction (Vomastek et al., 2008). 
The same study hinted at a role of TPR in modulating the translocation of ERK2 into the nucleus. 
Furthermore, it has been shown that protein degradation can be linked to specific cellular 
compartments like the endoplasmic reticulum (ER) in a process called ER-associated degradation 
(ERAD) (Christianson and Ye, 2014). Based on our results, we hypothesize that NIPA could act as a 
“cyclin trap” at the nuclear pore complex by degrading its target cyclinB1 upon premature entry into 
the nucleus in interphase.  Further studies will give important insights into the functional role of the 
cell cycle regulator NIPA at the nuclear envelope. 
3.2.1 Limitations of photobleaching methods 
The majority of today’s imaging methods are based on fluorescent labels. This has the great advantage 
of multiplexing several molecules labeled with different colors combined with a very high contrast. For 
in vivo imaging approaches, usually fluorescent proteins are utilized. Besides GFP, a large variety of 
proteins with excitation and emission maxima in different wavelengths are available (Crivat and 
Taraska, 2012). The attachment of these large fluorescent proteins (about 30 kDa) can, however, 
change the properties of the tagged proteins. Therefore, immunofluorescent control experiments 
confirming the localization of the protein are required. If the location of the endogenous protein is 
different, methods based on fluorescent tags cannot be applied. For instance, the localization of Uhrf1 
is still ambiguous as described in 3.1.2 and is probably influenced by the GFP-tag. Furthermore, 
experiments involving irreversible bleaching of labeled molecules might introducing phototoxic effects 
and thus damage the living cells. The influence of DNA damage on FRAP data has been only 
superficially investigated, because it has been assumed that no effects arise in the short period of 
acquisition. However, recruitment of Dnmt1 to damage sites has been already recorded in a time 
period as short as two minutes (Mortusewicz et al., 2005) and the period of image acquisition after 
bleaching can be extended to multiple hours (Bonisch et al., 2012). In addition, it has been reported 
that scattering of light could even induce photodamage in neighboring cells (Dobrucki et al., 2007).  In 
our experiments we did not detect damaging effects in the desired observation times. However, it is 
very hard to exclude hidden effects that might influence the kinetics.  
Besides the potential effects of cellular damage, cell movement is a known problem of photobleaching 
experiments (Goldman and Spector, 2005, Trembecka et al., 2010). The combination of image 
registration and a minimal total region of interest (ROI) have improved the evaluation, but only a 
perfect image registration gives absolutely reliable results. Especially half nucleus FRAP is challenging, 
because the loss of fluorescence is interpreted by the image registration algorithms as a strong 
movement of the cell and the registration of the last prebleach and the first postbleach images was 
not possible. Bleaching of a specific line or circle circumvents this problem, because the outline of the 
nucleus is always visible, but the averaged signal to noise ratio decreases due to the smaller area of 
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the bleached region. Moreover, the nuclear positioning of the small bleach regions influences the 
results, especially when placed at the boundary of the compartment (Mai et al., 2013). Furthermore, 
half nucleus FRAP is beneficial, if the localization is heterogeneous and the different compartments 
are too small to be selectively bleached. This is, for example, the case for the very small replication 
foci, Dnmt1 binds to in early S phase. Another effect that needs to be avoided is axial drift, which is 
often caused by temperature fluctuations. Therefore, a stable temperature outside and inside the 
incubator is recommended. In long-term FLIP or FRAP experiments, the imaging of z-stacks over time 
helps to detect and to compensate for axial drift (Bonisch et al., 2012). 
The photoswitching properties of the fluorophore are often neglected in photobleaching experiments. 
Upon excitation some molecules are transformed to non-fluorescent dark states (Dickson et al., 1997). 
In this state, bleaching of the molecules is very likely. However, a small fraction of the GFP molecules 
can revert from this state in a process called photoswitching (Bourgeois et al., 2012). The size of this 
fraction is influenced by the excitation intensity, which is changing between acquisition and bleaching, 
whereupon the size of this fraction is changing. Hence, after bleaching, a part of the molecules 
switches back to the fluorescent state, which is noticeable as a small recovery of the average 
fluorescence in the whole nucleus after bleaching. Photoswitching was like bleaching by acquisition 
corrected to a large extent in the FRAP evaluation procedure. Recently, specialized corrections have 
been developed and should be implemented into the standard evaluation (Mueller et al., 2012). All in 
all, a lot of improvements have been made to increase the reproducibility of FRAP results by refining 
the evaluation for a more robust outcome of FRAP experiments. 
3.2.2 Dependence of the model choice on the scientific question 
The quantification of the results of a FRAP experiment is critical to provide objective parameters 
describing the curves. Usually, the FRAP curve is described by a mathematical equation with specific 
fixed and variable parameters. The process of finding the variable parameters of the equation that 
describe the curve optimally is referred to as fitting. Besides fitting the curve with simple exponential 
equations, several mathematical models are available consisting of sets of equations based on physical 
laws. The mathematical models include diffusion models, diffusion-reaction models and 
compartmental models (Figure 12). Choosing the appropriate fitting procedure out of the existing pool 
is not trivial and can lead to inaccurate results (Mueller et al., 2008). Kinetic models often depend on a 
specific geometry of the bleached region and the FRAP approach needs to be adjusted accordingly. 
Furthermore, the choice depends on the homogeneity of the dynamic populations. Often, the proteins 
do not only interact with one, but with multiple interaction partners. If the interactions are 
characterized by distinct association rates (kon) and dissociation rates (koff), they can be separated in 
the fit. However, if kon and koff values of interactions are too similar, they cannot be separated. 
Therefore, we are using the term mobility class (MC) to describe a dynamic subpopulation. Moreover, 
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a MC must not necessarily describe an interaction, but could also arise, for instance, from atypical 
diffusion like anomalous diffusion. The reciprocal of koff is the Tres indicating the average binding time 
of the protein, if a single interaction is characterized. 
 
Figure 12: Choosing the appropriate model for the quantitative evaluation of FRAP experiments. (A) FRAP curves can be 
fitted with an exponential equation or a sum of exponential equations. The resulting t1/2 and MF are dependent on the size 
and geometry of the bleached region and can only be compared to equivalent experiments. The other models are based on 
physical laws and allow the quantification of diffusion coefficients and/or association and dissociation coefficients (kon/koff), 
as depicted. (B) Flowchart representing the decision path leading to the choice of the appropriate model. If the number of 
interactions cannot be predicted, the results of different models need to be compared. 
Sum of exponentials 
The simplest equation to fit the corrected and normalized FRAP curve is an exponential equation 
(Phair et al., 2004a). From the exponent of the solution that yields the best fit, the half time recovery 
(t1/2) can be calculated. If the curve does not approximate 1 during the recorded timeframe, the 
mobile fraction (MF) should be extracted as a second parameter. However, this value is dependent on 
the time the recovery has been recorded. Most FRAP curves extracted from nuclear proteins contain 
more than one MC and have therefore to be fitted with a sum of exponential equations (Phair et al., 
2004b). This will result in multiple t1/2 and a segmentation of the total populations into separate 
fractions. The decision of how many populations are present is not trivial and has to be carefully 
assessed (see 3.2.3). Using this method, proteins with different kinetic populations can be compared 
with each other. This has been applied before to study the number of kinetically distinct populations 
of the RNA polymerase II (Darzacq et al., 2007). We have fitted data with the sum of exponentials to 
analyze of kinetic populations of the canonical H2A.Z and a splice variant H2A.Z.2.2 (Bonisch et al., 
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2012). H2A.Z and its splice variant contain different fractions of highly mobile and rather immobile 
proteins. The FRAP experiments revealed large differences between the relative amount of 
nucleosomal incorporation of the different constructs (see 3.1.3). However, the resulting parameters 
are not absolute values, but describe the protein in the chosen setup relative to other proteins and 
can only be used for a comparative analysis. 
Diffusion model 
Whenever absolute values like diffusion coefficients or association or dissociation rates (Df, kon, koff) 
are required, special mathematical models have to be applied that are based on physical principles. 
The resulting parameters are protein specific and in principle independent of the setup. The models 
have to be tailored to the experimental approach or vice versa. One of the most frequently used 
models is the diffusion model. This requires data from a FRAP experiment with a specific geometry of 
the bleached region in order to determine the diffusion coefficient. Usually, the geometries include 
spot, spot array, rectangle or line bleaching (Hagen et al., 2009, Kang et al., 2012, van Royen et al., 
2009, Xiong et al., 2014), but by subdividing the nucleus in squared regions, the diffusion coefficient 
can even be extracted from half nucleus FRAP (Beaudouin et al., 2006). In the last decades, 
sophisticated models have been developed, including a range of parameters like the bleach profile, 
nuclear 3D geometry or bleach duration (van Royen et al., 2009, Mazza et al., 2007, Braga et al., 2004). 
The more measurable parameters are taken into account the more realistic the results should be. We 
have applied spot FRAP in combination with a diffusion model for the analysis of the diffusion of 
oligonucleotides in nanoparticles (Lebold et al., 2012). Based on the assumption that the diffusion rate 
of the nucleotides inside the particles is correlated with the diffusion of nucleotides into the particles, 
we found interesting differences. The diffusion is dependent on the functionalizations of the particles 
as well as on the length of the oligonucleotides (see 3.2.4). Interestingly, we identified a second 
diffusion rate, which was rather independent of oligonucleotide length and particle functionalization. 
The nature of the second population is unclear, but one explanation would be that at least two types 
of diffusion are present. Studies using particle tracking give a much more detailed picture on the 
random walks of the molecules and allow the differentiation of a large number of diffusion types. 
Particle tracking has been applied to single dye molecules in nanoparticles (Kirstein et al., 2007). 
Analyzing the mean square displacement over time revealed indeed different types of structured and 
unstructured diffusion. A mixture of these different subclasses could lead to the second class, we 
observed.  
Reaction-diffusion model 
Even more complexity is generated in reaction-diffusion models that introduces one MC to the 
diffusion model (Sprague et al., 2004). The mobility class is described by kon and koff and the 
corresponding fractions of free and bound protein are determined, adding at least three more 
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parameters to the model. As most nuclear proteins diffuse and have at least one specific interaction 
partner, reaction-diffusion models are widely used in order to quantify FRAP-based molecular kinetics. 
Examples include RNA, transcription factors or HP1 (Braga et al., 2007, Sprague et al., 2004, Muller et 
al., 2009). However, extension of these models to two or more MCs is mathematically very 
complicated and in general not used for data obtained by FRAP experiments. 
Compartmental model 
If more than one interaction has to be quantified, a different type of model has to be applied. The only 
solution so far is a compartmental model that comes with the disadvantage of neglecting diffusion. 
This means that it is only applicable to proteins that diffuse so fast that all free proteins of the whole 
nucleus are bleached by the time of the first postbleach image is recorded. In contrast, binding has to 
be so strong that no proteins unbind during the short time between bleaching and recording the first 
postbleach image. Although compartmental models have been applied for a range of proteins (Phair 
et al., 2004b), most of them do not provide the necessary prerequisites. Hence, ignoring diffusion can 
lead to an incorrect estimation of binding time (Sprague et al., 2006). In order to address this problem, 
we have implemented a size-dependent correction factor for diffusion in the compartmental model 
used for half nucleus FRAP (Schneider et al., 2013). In our approach, GFP-multimers were analyzed in 
order to approximate the diffusion of proteins of different sizes in the nucleus. Besides the apparent 
advantage, the measurement of the correction factor is also error prone, because not only the 
molecular size, but also the shape of the control protein has to resemble the protein of interest in 
order to estimate diffusion correctly. Furthermore, the factor kdiff is only a correction factor and does 
not give information about the diffusion coefficient. 
Often more than one model is applicable to the dataset, which generates the possibility to compare 
them with each other. For example, a protein with one MC should give the same koff with a reaction 
diffusion model and with a compartmental model. First comparisons have revealed significant 
differences between the kon and koff values of the glucocorticoid receptor obtained with different 
bleach geometries in connection with different models (Mueller et al., 2008). By comparing the 
approaches, the errors were identified and the resulting improved model was applied to other 
transcription factors. So far no gold standard has been established for the quantification of FRAP 
experiments. This would be a major benefit as results obtained with different experimental 
parameters and different quantifications could be easily compared. 
3.2.3 Limitations of the FRAP-based kinetic modeling 
All the mathematical models try to reproduce reality, but have to be always a simplified version. 
Therefore, the user has to keep in mind the known limitations of these methods. All the described 
fitting options have the problem of potential overfitting (Mai et al., 2011). The more variable 
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parameters are included in a model, the closer the fit will be to the curve. Especially models with 
multiple MCs harbor a variety of parameters. Therefore, parameters have to be approximated and 
fixed in order to gain valuable results. In our approach, we have quantified the fraction of bleached 
molecules and fixed the koff value of the MC with the slowest mobility (Schneider et al., 2013). 
Assuming that the slowest MC represents the catalytic reaction of Dnmt1, we based our estimations 
on in vitro data that have reported a dissociation rate of about 0.005 s-1, which is equivalent to a mean 
residence time of 200 s (Song et al., 2011). After fixing the parameters, it has to be tested, whether a 
model with less MCs would give similar results compared to a model with more MCs. The model with 
the smallest numbers of parameters should always be preferred. The determination of the number of 
MCs is referred to as model choice, because different models for the various numbers of MCs exist. 
We have established specific model choice rules in order to choose the appropriate number of MCs 
for GFP-Dnmt1 in each cell cycle stage. The application of standard model choice criteria like the 
Akaike information criterion (Akaike, 1973) was not successful as the differences between the quality 
of the fits were too small. In order to obtain robust results, we wanted to find a way to model 
parameters that fit multiple cells instead of fitting individual cells and averaging the results. Therefore, 
we have included mixed-effects into a nonlinear regression model in a Bayesian framework (see 2.8). 
In order to assess this approach, the equations were based on a simplified compartmental model that 
neglects diffusion, but allows an analytical solution of the differential equations. The proposed mixed-
effects model provides a much better fit than the fixed-effects model I and is thus more robust. This 
indicates that implementation of mixed-effects in more complex models can improve the robustness 
of the results. 
Another limitation is the focus of FRAP models on the koff. Changes in the kon value influence the 
protein dynamics in the cell. For instance, a protein that binds with high affinity and specificity to its 
target, but stays associated only for a short time might give very similar kinetics as a protein that 
diffuses very slowly through the cell (Figure 13). In both cases, the FRAP curves can look very similar. 
The phenomenon that proteins that bind with high affinity to their targets and therefore diffuse only 
very short distances until the next binding site is present has been described as diffusion-coupled 
FRAP recovery (Sprague and McNally, 2005). As this diffusion-coupled recovery is often not corrected, 
the Tres values present an upper limit of the real value, because short times of diffusion might have 
interrupted this estimated binding time (Mueller et al., 2008). There are ways to detect diffusion-
coupled recovery (Beaudouin et al., 2006), however, the ability to discriminate between those two 
cases is still limited. 
A third limitation is that most models only account for normal Brownian diffusion. However, there is 
increasing evidence that diffusion in the nucleus is anomalous (Bancaud et al., 2009, Wachsmuth et 
al., 2000). This means that the root mean square displacement is not directly proportional to time. The 
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reasons are suspected in the crowded environment leading to hindrance of diffusion by obstacles or 
corralling in labyrinth-like environments (Sokolov, 2012, Saxton, 2001). A model for anomalous 
diffusion in point FRAP experiments have been developed recently (Daddysman and Fecko, 2013). The 
authors reported that diffusion in HeLa nuclei is anomalous and that GFP seems to diffuse according to 
normal diffusion in chromatin free regions in polytene drosophila nuclei.  
 
Figure 13: Intermixing of diffusion and binding in FRAP. Very similar FRAP curves can be explained by different kinetic 
properties of the molecules. Either, molecules that diffuse very fast and have large kon and koff values (red) or molecules that 
diffuse very slow and have no specific interaction (blue) could result in the illustrated kinetics.  
In order to overcome these limitations in the future, cross validation of the results not only with other 
models, but also with other techniques using fluorescently labeled proteins in living cells should be 
conducted. The techniques include FCS and SPT. Both methods can be applied to extract diffusion 
coefficients and residence times. Recently, point FRAP and FCS have even been combined in one setup 
in order to gain comparable results with both methods (Im et al., 2013). In this way the cross 
validation is performed in one single experiment. Another approach has used data obtained with SPT 
in order to choose the correct model for FRAP and FCS analysis (Mazza et al., 2012). Here, all three 
methods were used to validate the results. With this approach they were able to detect and solve 
discrepancies in residence time and the fraction of bound protein. FCS is mainly used to determine 
diffusion rates of proteins, but with fluorescence cross correlation spectroscopy (FCCS) binding 
kinetics can be specifically determined between two differently labeled proteins and their diffusion 
coefficients can be directly compared (Schwille et al., 1997). This has the advantage that the binding 
partner is known, whereas in FRAP experiments this can only be indirectly determined by mutational 
analysis. Advantages of SPT and FCS are the drastic reduced phototoxic effect compared to FRAP as 
bleaching is not necessary. However, FRAP provides a much more global picture of dynamics inside a 
cell.  
3.2.4 Application of complementary methods  
Besides photobleaching methods, several other tools in fluorescence microscopy enable us to obtain 
detailed information about spatial and temporal regulation of molecules. Labeling proteins in in vivo 
experiments is commonly used, but DNA sequences have been so far mainly labeled in in vitro FISH 
experiments. We have applied dTALEs to visualize major satellite (ms) repetitive DNA sequences in the 
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nucleus in living cells (msTALE) (Thanisch et al., 2013). This enabled us to follow the movement of 
these repetitive sequences during the cell cycle or even differentiation. Instead, fluorescently tagged 
proteins like HP1 or MBDs have been used to visualize methylated sequences in vivo. Disadvantages 
are that heterochromatin-binding proteins might be specifically regulated in the cell. For instance, HP1 
is displaced from chromatin by H3S10 phosphorylation in G2 (Hirota et al., 2005). We showed that our 
msTALE is still bound in G2, even when HP1 is diffusively localized in the nucleus. Recently, two more 
publications have also demonstrated the application of dTALEs to label repetitive DNA sequences 
(Miyanari et al., 2013, Ma et al., 2013). They demonstrated that also repetitive sequences like 
telomeres or minor satellites can be labeled. Furthermore, application of the bacterial CRISPR/Cas 
system, which is like the TAL effectors adaptable for site-specific genome engineering, even allowed 
the detection of single loci (Chen et al., 2013). Our analysis of the binding dynamics by FRAP revealed 
that the msTALE binds much stronger to DNA than a polydactyl Zn Finger (PZF:GFP) construct directed 
against a similar sequence (Lindhout et al., 2007). As it has been reported that the localization of DNA 
influences the transcriptional activity of the corresponding sequences (Reddy et al., 2008), the strong 
binding of the msTALE could be exploited to manipulate chromatic regions. It has been shown in 
zygotes that fusion of the nuclear envelope protein emerin to a polydactyl Zn Finger, binding to major 
satellite sequences, tethers pericentromeric heterochromatin to the nuclear periphery (Jachowicz et 
al., 2013). The authors found that their manipulation lead to defective silencing of pericentromeric 
heterochromatin and impaired development of the embryos. 
The application of FRAP also gave valuable results for the characterization of other tools. We have 
used this method to learn about the diffusion of oligonucleotides in nanoparticles. The nanoparticles 
might be versatile vehicles to enable transport of proteins in single cells or whole tissues. We 
demonstrated that unfunctionalized and cyanopropyl-functionalized particles cannot be loaded with 
oligonucleotides (Lebold et al., 2012). Addition of aminopropyl or a combination of aminopropyl and 
phenyl groups enabled loading of the particles with siRNA. Furthermore it is possible to load fairly long 
oligonucleotides of 90 base pairs of DNA into the particles. Further fine-tuning of the 
functionalizations of the particles could result in vectors with different properties, like fast or slow 
release of nucleic acids, for different purposes. These findings are valuable when it comes to using the 
nanoparticles as carriers of therapeutics.  
Besides labeling and delivery also high resolution spatial information is very valuable. Using super-
resolution 3D-SIM microscopy, we analyzed not only in detail the association of Dnmt1 to 
chromocenters in late S phase, but also the detailed localization of NIPA at the nuclear envelope. We 
demonstrated that the latter is localized slightly inside the nuclear lamina and the nucleoporin 
Nup153, but on the same level as its interaction partner TPR. Increasing resolution is also gained with 
other methods like STED or localization microscopy (PALM, dSTORM). However, these methods lack 
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the increased z-resolution of 3D-SIM and only a maximum of two labels can be multiplexed 
(Schermelleh et al., 2010). However, they are being further developed and for localization microscopy 
first setups have reported an axial resolution of up to 20 nm (Xu et al., 2012). 
3.3 Outlook 
Besides our new findings and developments, many new ideas and questions are arising. We have 
shown that FRAP is a very powerful tool to study the nuclear dynamics in vivo. Therefore, further 
developments of this technique are still of great interest. Especially the combination with new 
technical innovations can extend the applicability of this method. Automation of not only the 
evaluation, but also the acquisition of imaging data has been further developed. Both, automated 
detection of cellular features and automated imaging at multiple positions have been demonstrated 
and the latter is already implicated in many commercial microscopy systems (Held et al., 2010, Conrad 
and Gerlich, 2010, Edelstein et al., 2010). Recently, these techniques have been combined, enabling 
automated FRAP on a confocal microscope (Conrad et al., 2011). A low resolution image is acquired in 
a defined region and immediately analyzed by the software Micropilot (Figure 14). If a cell in this 
image fulfills the preset requirements, a FRAP experiment with the selected cell is automatically 
started and recorded. Then, the scanning process is continued by acquisition of further low resolution 
images in the predefined area. The great advantage of performing experiments with a long recovery 
time without the need of intermediate user interactions allows the performance of FRAP experiments 
overnight. RNAi screens using automated confocal imaging have been successfully performed in the 
past (Neumann et al., 2010). Using Micropilot, FRAP-based screens can be run, gaining information 
about the localization and the kinetics of the proteins at the same time. Automatic FRAP experiments 
produce large datasets and generate the requirement for efficient data handling and processing. The 
macros for FRAP evaluation that have been developed in this thesis, could be further automatized and 
extended by adding quality criteria to automatically detect factors like z-drift. 
 
Figure 14: Automatic FRAP experiment. In order to detect cells fulfilling preset requirements, a low resolution image is 
acquired in a defined area. The image is analyzed by the software Micropilot. If a suitable cell is detected (red outline), a 
FRAP experiment is started. When the FRAP experiment is finished or If no suitable cell can be detected, the stage is moved 
and the next low resolution image in the defined area is acquired. The procedure will be repeated until the defined area has 
been scanned. 
Furthermore, the evaluation at a single cell level could be enhanced by measuring the recovery in 
every pixel. Plotting the results in form of a heat map in the nucleus enhances the spatial resolution of 
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FRAP and diffusion-coupled kinetics in the nucleus could be illustrated. Usually the presence of 
diffusion-coupled kinetics is tested in an approach, in which the nucleus is segmented into stripes and 
differences in the kinetics are analyzed in respect to the distance to the bleach border (Beaudouin et 
al., 2006). In order to gain more resolution in FRAP experiments, one could also think of implementing 
a scanning system for bleaching in the widefield path of 3D-SIM microscopes that are fast enough for 
super-resolution live cell imaging (Shao et al., 2011). The fusion of both methods would allow maps of 
protein dynamics in relation to a marker protein with very high resolution. 
Not only technical issues need to be addressed. Due to recent findings, new questions emerged 
regarding epigenetics and especially Dnmt1. Recently, mutations in Dnmt1 have been linked to the 
diseases hereditary sensory and autonomic neuropathy type 1 (HSAN1) and autosomal dominant 
cerebellar ataxia, deafness and narcolepsy (ADCA-DN) (Winkelmann et al., 2012, Klein et al., 2011). 
Interestingly, all mutations were located in the TS domain. It will be interesting to apply our 
knowledge about Dnmt1 in order to unravel how Dnmt1 is mechanistically linked to this disease. 
Furthermore, discoveries about the influence of factors like RNA on Dnmt1 regulation have been 
made. They revealed that non-coding RNAs block Dnmt1-mediated methylation at a large number of 
gene loci (Di Ruscio et al., 2013). Using deep sequencing of RNA, DNA methylation in combination with 
proteomics, global information about the regulation of DNA methylation will be unraveled that is not 
anymore limited to single loci. Most importantly, the discovery of Tet proteins and their DNA 
modifications hmC, fC and caC has opened a new field of questions concerning the role and regulation 
of epigenetic marks that need to be addressed. 
In the future highly sophisticated techniques will be more and more important in order to understand 
biological questions. The interconnection of biological research and technology will help us to 
understand the dynamic regulation of epigenetic mechanisms in living cells, leading to further insights 
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ADCA-DN: autosomal dominant cerebellar ataxia, deafness and narcolepsy 
AID: activation induced cytidine deaminase 
APOBEC: apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 
BAH: bromo adjacent homology 
BBD: bar body deficient 




Df : diffusion coefficient 
DMAP1: Dnmt1-associated protein 1 
Dnmt: DNA methyltransferase   
dTALE: designer transcription activator-like effector 
EdU: ethynyldeoxyuridine 
ER: endoplasmic reticulum 
ERAD: ER-associated degradation 
ERK2: extracellular signal-regulated kinase 
ESC: embryonic stem cell 
Fab: fragment antigen-binding 
FCCS: fluorescence cross correlation spectroscopy 
FCS: fluorescence correlation spectroscopy 
FLIM: fluorescence lifetime imaging microscopy  
FLIP: fluorescence loss in photobleaching  
FRAP: fluorescence recovery after photobleaching 
FRET: Förster resonance energy transfer 
GFP: green fluorescent protein 
HDAC: histone deacetylase 
HSAN1: hereditary sensory and autonomic neuropathy type 1  
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koff : dissociation rate 
kon: association rate 
MBD: methyl-CpG-binding domain 
MBP: methyl-CpG-binding protein 
MC: mobility class 
Me: methylation 
MF: mobile fraction 
ms: major satellite 
NIPA: nuclear interaction partner of anaplastic lymphoma kinase 
NLS: nuclear localization signal 
NuA4: nucleosomal acetyltransferase of H4 
p400: E1A-binding protein p400 
PALM: photoactivated localization microscopy 
PBD: PCNA binding domain  
PBHD: polybromo homology domain 
PCNA: proliferating cell nuclear antigen 
PHD: plant homeodomain  
PZF: polydactyl zinc finger 
RFC: replication factor C 
RFP: red fluorescent protein 
RICS: raster scan image correlation spectroscopy  
RING: really interesting new gene 




SET: Suv39, Enhancer-of-zeste, Trithorax 
SPR: surface plasmon resonance 
SPT: single particle tracking 
SRA: SET and RING associated  
SRCAP: Snf2-Related CREBBP activator protein 
STED: stimulated emission depletion 
STORM: direct stochastic optical reconstruction microscopy 
Suv: suppressor of Variegation 
t1/2: half time recovery 
TDG: thymine-DNA glycosylase  
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Tet: ten-eleven- translocation 
Tip60: Tat-interactive protein 60 
TIRF: total internal reflection fluorescence 
TPR: translated promoter region 
Tres: mean residence time 
TS: targeting sequence 
TTD: tandem tudor domain 
Ub: ubiquitination 
Ubc9: ubiquitin carrier protein 
Ubl: ubiquitin-like 
Uhrf: ubiquitin-like, containing PHD and RING finger domains 
wt: wild type 
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